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ABSTRACT 
Since its discovery in 1955, amphotericin B (AmB) has been a vital clinical agent. It 
remains the drug of last resort for systemic fungal infections despite its significant toxicity. 
Despite over 50 years of clinical use, very few cases of AmB resistance have been reported. This 
lack of resistance has been attributed to its unique mechanism of action. AmB is hypothesized to 
bind to yeast membranes and self-assemble into membrane-spanning ion channels leading to cell 
death. AmB thus represents a prototype of a small molecule with capacity to perform protein-like 
function. However, despite extensive scientific inquiry, this capacity remains poorly understood. 
An atomistic understanding of this mechanism stands to enable efforts to harness this untapped 
potential and/or improve the therapeutic index of AmB. 
The leading model for AmB antifungal activity is self assembly of the natural product 
into discrete, membrane-embedded barrel-stave pores which disrupt cellular ion gradients and 
cause cell death. A ring of salt bridges and/or hydrogen bonds at the channel periphery are 
proposed to stabilize the channel assembly. These polar interactions are proposed to form 
between the C41 carboxylate and C3' amine of adjacent AmB molecules within the channel 
architecture.  
This dissertation describes experiments carried out to directly test these two major 
hypotheses of AmB antifungal activity. We have developed a functional group deletion strategy 
to directly test the role of the C41 carboxylate and C3' amine. Derivatives were prepared lacking 
either one or both of these functional groups and solution NMR conformational analysis was 
employed to determine the ground state conformation of AmB and our derivatives. The 
functional consequences of these deletions were then assessed in antifungal assays. Our results 
indicate that in stark contrast to the salt bridge hypothesis, oxidation at C41 is not required for 
antifungal activity. 
To test the long-standing hypothesis that AmB is primarily embedded as discrete ion 
channels in phospholipid bilayers, we have performed an extensive series of solid-state NMR 
experiments, including homonuclear (13C-13C) and heteronuclear (31P-13C, 1H-13C) correlation 
experiments and paramagnetic relaxation measurements.  These data sets enabled us to assign the 
13C signals of AmB and to assess geometric and topological aspects of the structural models. 
Strikingly, our results demonstrated that AmB primarily exists in extra-membranous aggregates 
phase-separated from membrane phospholipids. Moreover, PRE studies of ergosterol 
 ii
demonstrated that these large aggregates function to extract ergosterol from the lipid bilayer. The 
work described in this dissertation highlights the power of both solution and solid-state NMR for 
studying the function of small molecules. Moreover, these NMR experiments led to a new model 
for the antifungal activity of AmB in which large AmB aggregates bind to fungal cell 
membranes and extract ergosterol, thus depriving the cell of a functionally vital lipid. 
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CHAPTER 1 
Amphotericin B: A potent antifungal drug with capacity to perform protein-like function 
 
1-1 AMPHOTERICIN B: DRUG OF LAST RESORT FOR SYSTEMIC FUNGAL 
INFECTIONS 
Amphotericin B (AmB, 1) is a clinically 
vital antifungal agent1 used for treatment of severe 
fungal infections. Despite an expanding repertoire 
of antifungal agents in clinical use, life-
threatening fungal infections continue to be a 
threat to hospitalized patients, particularly those 
who are immunocompromised.2  The clinical success of AmB is a result of its broad spectrum of 
activity and infrequent incidence of fungal resistance to AmB–despite over 50 years of clinical 
use, very few instances of AmB resistance have been documented.3,4,5,6 The use of AmB is often 
limited by its severe toxicity, yet it remains the drug of last resort for life-threatening fungal 
infections. Use of newer antifugnal agents for these infections is often limited due to resistant 
strains of fungi. This problem is especially pronounced in the hospital setting where treatment-
resistant fungal infections are especially common. A recent epidemiological study7 of 49 U.S. 
hospitals from 1995 to 2002 found that Candida species were the 3rd most common cause of 
hospital-acquired bloodstream infections, accounting for 10% of such infections. The attributable 
mortality rate for these infections is reported to be 40%. Thus, there remains a pressing need for 
safer and more effective antifungal treatments 
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1-2 AMPHOTERICIN B: PROTOTYPE OF A SMALL MOLECULE WITH THE 
CAPACITY TO PERFORM PROTEIN-LIKE FUNCTION 
Lack of fungal resistance to AmB is typically attributed to its unique mechanism of 
action. For nearly 50 years,3,4,5,6 the leading model for its mechanism of action has been AmB 
self-assembly into a membrane-spanning ion channel which disrupts electrochemical gradients, 
ultimately causing cell death.2 AmB thus represents a prototype of a small molecule with the 
capacity to perform protein-like functions. A detailed molecular understanding of AmB channel 
activity stands to enable efforts to harness this potential and/or improve the poor therapeutic 
index of AmB. Despite over 50 years of intense research on the biophysical properties of AmB, 
the fundamental underpinnings of how it exerts its antifungal and channel activities remain 
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poorly understood.8   This chapter will detail efforts to understand the biophysical properties of 
AmB as well as the development and evolution of the ion channel model of AmB. 
1-3 EARLY BIOPHYSICAL STUDIES OF AMPHOTERICIN B 
First isolated in 1955 from the soil bacterium Streptomyces nodosus,9 AmB emerged at a 
time when no antifungal agents were available. AmB was thus rapidly investigated for potential 
clinical use, and in 1958 became the first antifungal drug approved in the United States. For 
decades, AmB was the treatment of choice for fungal infections, and, despite its toxicity, it 
remains the drug of last resort for severe fungal infections. 
In parallel with clinical investigation of AmB, studies of the biophysical properties of this 
new natural product were undertaken to determine its structure and mechanism of action. In 
1958, Gottlieb10 and coworkers reported the capacity of hexane extracts from carrots to rescue 
fungi from the fungicidal activity of AmB. Addition of these extracts to culture medium of P. 
oxalicum rendered these fungi resistant to AmB. Purification and analysis of a white solid from 
these carrot extracts identified a C29 sterol and it was proposed that sterols were involved in this 
protective mechanism. The authors thus hypothesized that AmB either inhibited the synthesis of 
membrane sterols or replaced sterol in a physiologically critical reaction.  
Shortly after publication of this report, alternative hypotheses were proposed to explain 
the connection between sterols and AmB antifungal activity.  Feingold demonstrated that AmB is 
lethal to the archaebacterium Mycoplasma laidlawii.11 These bacteria have no cell wall and no 
membrane sterols. When grown in media containing sterol, however, the cells incorporate this 
sterol into their membrane. M. laidlawii grown in sterol-rich media were sensitive to AmB, 
whereas cells grown in sterol-free media were refractory to AmB. Furthermore, inoculation of 
refractory cells from the sterol-free culture to sterol-rich media rendered these cells sensitive to 
AmB. Conversely, those cells grown in the presence of sterol became refractory to AmB when 
subsequently cultured in sterol-free media. These experiments demonstrated the requirement of 
membrane sterol for cytotoxic activity of AmB, but did not illuminate the specific role of sterols 
in facilitating AmB cytotoxicity.   
Follow-up studies in Acheloplasma laidlawii by DeKruijff12 and coworkers further 
probed the sterol-dependence of AmB. Sterol-dependent permeabilization of model membranes 
by AmB had been reported (see below), and DeKruijff tested in A. laidlawii the hypothesis that 
AmB would similarly permeabilize cellular membranes in sterol-dependent fashion. Addition of 
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AmB to suspensions of A. laidlawii grown in the presence of cholesterol resulted in rapid, robust 
efflux of K+ from the cells. In contrast, when AmB was added to suspensions of A. laidlawii 
grown under sterol-free conditions, no permeability was observed. A variety of sterols were then 
screened, and it was discovered that a 3β-hydroxyl group and a hydrophobic side chain at C17 
were required for permeability, implying a direct role of sterol in mediating cell membrane 
permeability.    
This membrane-permeabilizing activity of AmB garnered significant attention, yet the 
specifics of how AmB induces ion permeability remained unclear. Three possible mechanisms 
for this membrane-permeabilizing activity were explored in planar lipid bilayer conductance 
studies: physical destruction of the phospholipid bilayer, ionophoric transport, and discrete single 
ion channel formation. Planar lipid bilayers provided means to study AmB-induced conductance 
on small patches of membrane while also giving the researcher the ability to carefully control the 
composition of the membrane.  
Andreoli and Monahan13 studied the effects of AmB on planar lipid bilayers formed from 
sheep erythrocyte lipids. Upon addition of AmB, the resistance of the membrane decreased by 6 
orders of magnitude without disrupting the integrity of the membrane. When lipids used to form 
the membrane were sterol-depleted, AmB had no effect on membrane resistance or stability. This 
membrane stability in the presence of AmB argued strongly against membrane disruption as a 
mechanism through which AmB exerts its membrane permeabilizing activity.  
To investigate the possibility that AmB acts via ionophoric transport, Cass et al.14 
characterized the membrane conductance properties of AmB in comparison to the ionophoric 
peptide valinomycin. This protein acts as a carrier to bind and transport one potassium ion at a 
time across the membrane. Two key experiments identified fundamental differences in how these 
molecules create ion conductance. First, the relationship between concentration and conductance 
was measured. For valinomycin, conductance was directly proportional to concentration of 
valinomycin. The conductance in the presence of AmB increased as a function of [AmB]n, with n 
> 4. Temperature dependence of conductance was also measured. In the case of valinomycin, 
conductance increased with increasing temperature. For AmB, however, increases in temperature 
resulted in marked decrease in conductance. The stark contrast between these observations for 
valinomycin and AmB strongly support the conclusion that AmB does not function via an 
ionophoric mechanism. The properties of AmB-impregnated membranes in these experiments 
3 
are, however, consistent with a self-assembled supramolecular complex stabilized by non-
covalent interactions.  
In 1976, Ermishkin and coworkers15 reported single ion channel recordings produced by 
AmB in planar lipid bilayer experiments. This report marked the first definitive evidence for a 
discrete AmB ion channel with distinct electrophysiological properties. Strikingly, these channel 
recordings clearly displayed defined open and closed states, with a step function of constant 
amplitude for the open state just as would be observed for a protein ion channel (Figure 1-1). 
Moreover, events were observed in which the current doubled, consistent with opening of a 
second identical ion channel. Follow-up studies demonstrated that this ion channel could be 
blocked with tetraethylammonium cations, a property that has also been reported for some 
protein ion channels. While this discovery represented a major breakthrough in the 
understanding of the biophysical properties of AmB, the role of the AmB ion channel in 
antifungal activity, if any, remained unknown. However, this theory quickly took hold, and over 
30 years later, the AmB ion channel remains the leading model for the antifungal activity of 
AmB.  
 
Figure 1-1. Membrane current in the presence of 3 x 10-8 M AmB (A) and 1 x 10-7 M AmB (B). These single ion 
channel recordings of AmB in planar lipid bilayers provided the first direct evidence that AmB forms discrete ion 
channels with defined electrophysiological properties. Used with permission from Ermishkin et al. Nature 1976, 
262, 698-699. ©Nature Publishing Group 
1-4 DEVELOPMENT OF THE BARREL-STAVE MODEL FOR THE AMPHOTERICIN 
B ION CHANNEL 
The discovery of AmB also sparked the interest of natural products chemists, and efforts 
to elucidate the structure of AmB rapidly followed. Elucidating even the primary structure of 
complex natural products in the 1950s and 1960s was a long and laborious process, relying on 
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tedious attempts at crystallization and degradation to less complex products which could be fully 
characterized to draw conclusions about the structure of the parent natural product. Then, as if 
putting together a jigsaw puzzle of chemical structures, proposals were made for the structure of 
the natural product. Iterative application of this process by several research groups (including 
Dutcher,16 Cope,17 and Borowski18) culminated in the 1970 report of the full structure of AmB 
by Borowski and coworkers.18 That same year, the stereochemical assignments of the 19 
stereocenters of AmB were reported by Ganis and coworkers19 on the basis of crystallographic 
analysis of N-iodoacetyl AmB, and the full crystal structure, confirming Borowski’s structure, 
was reported the following year.  Borowski later confirmed20 by solution NMR conformational 
analysis that the solution conformation of the AmB monomer in pyridine/MeOH matched that 
observed in the crystal structure. 
HO
Me
Me
Me
Me
Me
H
H
Me
O
O
MeHO
Me
Me
O
OHO
HO CO2
OH
OH
OH
OH
HO
O
OH
NH3
OHMe
Ergosterol
35
AmB  
Figure 1-2. Schematic representation of the barrel stave AmB ion channel model.  
The discovery of the chemical structure of AmB directly enabled proposal of the now 
classic barrel-stave model of the self-assembled AmB ion channel (Figure 1-2).  In 1973-74, 
Andreoli,21 de Kruijff,12 and Finkelstein22 each proposed very similar structural models for the 
AmB ion channel, and elements of each contributed to the current leading model of the AmB ion 
channel. These models were based on the known biophysical properties of AmB in phospholipid 
bilayers, and yet are strikingly similar given that they were proposed in parallel.  Each model 
included the same general features:  
1. AmB assembles vertically (parallel to the bilayer normal) to form a pore such that the 
hydrophobic polyene is oriented toward the channel periphery, thus enabling van der 
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2. The AmB polyol is thus oriented inward toward the conductive portion of the channel, 
allowing water, ions, and small polar molecules to pass through.  
3. The assembled pore interacts with one leaflet of the bilayer. Conspicuously, AmB is ~24 
Ǻ in length, or approximately one-half the length of a physiological bilayer (ref. Andreoli 
1974).  
4. The pore has an interior diameter of approximately 7-10 Ǻ.12 This feature is based on the 
observations that glucose permeability through AmB-impregnated membranes is very 
low and sucrose has no permeability through such membranes.  
The model proposed by de Kruijff and Demel was based primarily on these 4 postulates and was 
constructed from CPK models of AmB and cholesterol (Figure 1-3) to form a barrel-stave pore. 
In addition, the authors proposed that either one of these ion channel pores spanned just one 
bilayer leaflet, and thus two adjacent pores were required to span the full bilayer or that the 
membrane dimples to match the length of a single AmB aggregate (Figure 1-4).23 
 
Figure 1-3. CPK model of the AmB ion channel reported by DeKruijff and Demel. Used with 
permission from de Kruijff and Demel R.A. Biochim. Biophys. Acta 1974, 339, 57-70. ©1974 
Elsevier B.V. ©Elsevier 
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Figure 1-4. DeKruijff and coworkers proposed two possible models for AmB pores in phospholipid 
membranes: either two pores are required to span the bilayer (right) or the bilayer dimples to match the length 
of a single pore. Used with permission from Gray, K.C.; Palacios, D.S.; Dailey, I.; Endo, M.M.; Uno, B.E.; 
Wilcock, B.C.; Burke, M.D. Proc. Natl. Acad. Sci. USA, 2012, 109, 2234-2239. ©2012 National Academy of 
Sciences of the United States of America 
Andreoli proposed a two-dimensional cross-sectional model which incorporated the 
additional observation that sterols with a 3β hydroxyl are required for AmB to induce membrane 
permeability (Figure 1-5) (ref Andreoli and de Kruijff). Specific hydrogen-bonding interactions 
were proposed, one involving the sterol hydroxyl proton and the carbonyl of the C41 carboxylate 
(Figure 1-5, left) and the other involving the sterol hydroxyl oxygen and the C17 hydroxyl 
proton. Interestingly, included in this report was the observation that the methyl ester of AmB 
induced membrane permeability and thus the proposed interaction to sterol involved the 
carbonyl, and not the -OH, of the C41 carboxyl group (see below for further discussion of the 
carboxyl and amine). Andreoli specifically commented that other polar interactions between the 
sterol and AmB were possible. This structural model did not go so far as to propose a channel 
stoichiometry or a 3-dimensional channel structure, stating simply, “it is amusing to note that a 
cylindrical structure…can be constructed from eight space-filling models of ampohotericin B 
that alternate with cholesterol models.”      
7 
 
Figure 1-5. Cross sectional view of the model of the AmB ion channel proposed by Andreoli. Used with permission 
from Andreoli, T. Ann. N.Y. Acad. Sci. 1974, 235, 448-468. ©John Wiley & Sons, Inc. 
1-5 SALT BRIDGE MODEL OF CHANNEL STABILIZATION 
The now classic barrel-stave model was further refined in subsequent years to include a 
proposed intermolecular ring of stabilization of the AmB ion channel by polar interactions 
between the functional groups at C41 and C3'.  Kasumov et al.24 proposed these polar 
interactions on the basis of single ion channel recordings of AmB and two derivatives covalently 
modified at either C41 or C3', AmB methyl ester (AmE), and N-acyl AmB. These derivatives 
gave rise to a much shorter active channel lifetime, 
and thus there was a much lower probability that 
these channels were conducting ions at any given 
time. Moreover, both AmE and N-acyl AmB required 
much higher concentrations to form ion channels. 
Interestingly, the conductance of the three ion channel 
recordings did not vary significantly among the three 
molecules. The authors concluded that the loss of 
charged groups at the C41 and C3' positions led to a 
less stable ion channel due to a loss of electrostatic 
stabilization. Thus, the stability of the native AmB 
ion channel was assumed to be associated with 
electrostatic interactions between C41 and C3'.   
Figure 1-6. Schematic “top-down” view of 
the barrel-stave ion channel model with 
intermolecular salt bridges marked with 
purple dashes. Adapted with permission from 
Palacios, D.S.; Anderson, T.M.; Burke, M.D. 
J. Am. Chem. Soc.  2007, 129, 13804-13805. 
©2007 American Chemical Society. Two considerations complicate interpretation 
of structure/function data for covalently modified 
8 
AmB derivatives. First, self-assembly of small molecules is remarkably sensitive to steric 
perturbations.25,26 As a result, discriminating between steric effects and disruption of hydrogen 
bonding is challenging. Second, as noted by Borowski et al.,27 AmB derivatives esterified at C41 
retain a polar carbonyl and still possess the ability to form polar interactions with mycosamine. 
Borowski specifically proposed that the carbonyl of the methyl ester of AmB retains this 
capacity and therefore retains capacity for channel formation and fungicidal activity.  
Conspicuously, the carboxyl and amine groups proposed to be critical for channel 
stabilization are installed biosynthetically as post-polyketide synthase (PKS) modifications of the 
macrolide core (Figure 1-7)28,29. PKS enzymes assemble this core structure of AmB, after which 
tailoring enzymes complete the biosynthesis: AmphL cytochrome P450, AmphN cytochrome 
P450, and AmphDI glycosyl transferase enzymes catalyze installation of the C8 alcohol, 
exhaustive oxidation at C41, and attachment of mycosamine to the C19 alcohol, respectively. 
 
Figure 1-7. AmB is biosynthesized via PKS enzymes. Post-PKS tailoring modificatins install the C41 carboxyl and 
mycosamine, the 2 functional groups predicted to be critical for stabilizing the active ion channel. 
The salt bridge hypothesis was further supported by computational modeling studies. The 
first of these studies was a molecular mechanics study.30 These calculations predicted a 4.6 Ǻ 
distance between the carboxyl and amine, and the stabilization of the complex was attributed 
primarily to these 8 salt bridge interactions. Subsequently, molecular dynamics simulations were 
performed by McCammon and coworkers.31 These calculations similarly predicted 
intermolecular hydrogen bonding between adjacent carboxylate and amine groups as the primary 
force for stabilizing the channel complex. A second molecular dynamics study by Baginski and 
coworkers32 again predicted this ring of hydrogen bond stabilization. Interestingly, these 
interactions were calculated to be stronger in the presence of ergosterol than when cholesterol 
was used as the sterol between AmB molecules. The authors emphasized that derivatives that 
modify the amine likely perturb this hydrogen bonding interaction leading to an inactive 
compound.  A major limitation of computational studies such as those discussed here is that they 
are designed to study the AmB ion channel and starting conditions for the calculations arrange 
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AmB in a channel-like AmB assembly. Thus, the results are biased toward the existing ion 
channel and salt bridge model.  
Many studies have probed contributions of the C41 carboxylate and C3' ammonium to 
AmB channel and antifungal activity by covalent modification at these positions.8e,33,34,35 Briefly, 
N-acylated AmB derivatives are inactive, whereas esterification at C41 produces derivatives 
which are roughly equipotent to AmB itself. Borowski and coworkers33 have reported an 
extensive series of derivatives esterified at C41 and/or alkylated/acylated at C3' that 
demonstrated this trend. It was reported that a positive charge at the amine was required to 
maintain antifungal and K+ efflux activity, while a variety of ester substituents were tolerated at 
C41 without a significant decrease in activity.   
Another example of this approach36 is 
the report by Murata and coworkers in which 
intramolecular bridges were used to link the 
C41 carboxylate directly to the C3' amine ( 
1.3-1.5). These compounds had markedly 
diminished antifungal and K+ efflux activity, 
with the exception of 1.4 with n=5 which had 
good efflux activity but poor antifungal 
activity. Based on modeling of this compound, 
the authors drew conclusions about the active 
conformation of AmB.  
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Another example8e of the covalent modifications approach is the AmB-fluorescein 
conjugate (1.6) synthesized by Carreira and coworkers. This compound displayed K+-efflux 
activity but was completely inactive in antifungal assays. Fluorescence and microscopy studies 
of this compound in yeast and mammalian cells showed that the molecule localized inside 
mammalian cells but was localized at the membrane in yeast cells.  
1-6 SOLUTION NMR STUDIES OF AMPHOTERICIN B 
Due to inherent size limitations, solution NMR has been of limited utility to study the 
function of AmB. However, this technique has proved useful for studying the structure of 
monomeric AmB in solution. In 1992, Borowski20 and coworkers reported a solution NMR 
conformational analysis of AmB protected at C41 as the methoxycarbonylmethylamide. 1H 
10 
coupling constants were used to calculate dihedral angles according to Karplus relationships,37 
and ROESY studies were employed to identify proximal protons. From these data, a structure 
was proposed. This structure was in very good agreement with the N-iodoacetyl AmB crystal 
structure, thus demonstrating that AmB derivatives bearing covalent modifications at C41 or C3' 
have the same ground state conformation.  
1-7 SOLID-STATE NMR STUDIES OF AMPHOTERICIN B 
OH
 
In attempts to study the AmB ion channel, Murata and coworkers38 employed rotational 
echo double resonance39 (REDOR) SSNMR experiments for AmB in the presence of lipid 
bilayers. The REDOR experiment identifies 13C nuclei proximal to phospholipid 31P nuclei by 
taking advantage of the dipolar coupling interaction between these nuclei. It is thus possible to 
assess whether a nucleus resides proximal to the phospholipid head group. Biosynthetically 
prepared28 tri-13C-AmB (1.7) was used in this initial report. In this study, multi-lamellar vesicles 
(MLVs) composed of 1.7 and the fully saturated lipids 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) or 1,2-distearoyl-sn-glycero-3-phosphochiline (DSPC) were analyzed 
for REDOR dephasing of AmB 13C nuclei by lipid 31P nuclei. Modest dephasing was observed 
for all three 13C labels of tri-13C-AmB in the presence of DMPC. In the presence of DSPC, 
dephasing was observed only at the carboxyl carbon. From these results, it was concluded that 
AmB inserts vertically in bilayer membranes and forms a double pore channel in the presence of 
DSPC and a single pore channel in the presence of the shorter DMPC. These results are depicted 
in Figure 1-8. 
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Figure 1-8. Visual depiction of REDOR dephasing and subsequent interpretation. A) In the presence of DMPC or 
DLPC (no sterol present), the nuclei shown in red are moderately dephased. This was interpreted as evidence for a 
single pore membrane-spanning channel, depicted schematically with red arrows indicating sites of REDOR 
dephasing. B) When longer DSPC lipids are used, only C41 (red) is moderately dephased. This was interpreted as 
evidence for a double pore channel..  
 Two limitations of these experiments are noteworthy. First, the lipid system was devoid 
of sterol, yet AmB is known to manifest its biological activity only in membranes containing 
sterols.40 Second, the lipids used in these studies were fully saturated, whereas biological 
membranes contain a substantial proportion of unsaturated lipids. As described in Chapter 3, this 
distinction has important biophysical consequences that impact the activity of AmB.  
A follow-up study41 examined uniformly 13C-labelled AmB (~15% 13C incorporation) in 
vesicles comprised of an alternative phospholipid, 1,2-dilauroyl-sn-glycero-3-phosphochline, 
which possess very short (C12) and fully saturated acyl chains.. Modest REDOR dephasing was 
again observed for the C41 and C38/C39 sites, but no REDOR dephasing was reported for 
carbons comprising the polyene region. From these data, it was concluded that, in this bilayer 
comprised of very short lipids, AmB is inserted into the membrane and a single barrel spans the 
entire membrane. Again, the use of sterol-free unsaturated lipids compromise the significance of 
these studies. The use of C12 acyl chains, which are rarely observed in natural systems, raises 
further questions regarding the physiological relevance of these findings. These results are also 
depicted in Figure 1-8.  
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Another SSNMR study42 
by Murata and coworkers analyzed 
a fluorinated ergosterol derivative 
(F-erg, 1.8, Figure 1-9A) in the 
presence of U-13C-AmB in DMPC 
MLVs. 13C-19F REDOR studies 
were performed, but no REDOR 
dephasing of AmB was observed. 
A tethered F-erg / AmB conjugate 
(1.9, Figure 1-9B) was synthesized 
and REDOR studies were 
performed on this molecule. 
REDOR dephasing of AmB C1' 
and the AmB polyene were observed. It was concluded due to the lack of intermolecular 13C-19F 
REDOR effects that ergosterol may be surrounding the AmB ion channel, rather than 
interdigtiated with AmB.  
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Figure 1-9. A) No REDOR dephasing was observed for AmB in 
the presence of F-erg. B) When F-erg was tethered to AmB, 
REDOR dephasing was observed to C1' and the AmB polyene.  
In another series of studies,43 Murata and coworkers studied orientation effects of the 
sugar. To do this, tethered molecules were synthesized in which the C41 carboxyl was tethered 
to the amine through an intramolecular bridge. One such compound (1.10, Figure1.10), 
contained a 1-13C-, 15N-glycine linker. This compound was incorporated into DMPC MLVs 
containing ergosterol for SSNMR analysis. The dipolar coupling for this 13C-15N pair was 
measured to be ~200 Hz, and from this it was concluded that the molecule was immobilized on a 
timescale of >5 ms (1/200 Hz). The authors thus concluded that this derivative existed in a rigid 
limit and therefore was part of a complex greater than 20 nm in diameter.   
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Figure 1-10. An intramolecularly bridged derivative was judged to immobilize as 
part of a >20 nm complex in DMPC liposomes on the basis of a C-N dipolar 
coupling of 200 Hz. 
The Murata group has more recently reported some SSNMR studies in MLVs derived 
from the mixed saturated, unsaturated lipid POPC (1.11). The first of these studies44 sought to 
more fully characterize the AmB ion channel by mixing 14-fluoro-AmB (1.12) and tri-13C-AmB 
in POPC liposomes. 13C-19F REDOR was thus used to measure the intermolecular 13C-19F 
dephasing at AmB C41. In POPC MLVs lacking sterol as well as those incorporating cholesterol, 
the 13C-19F distance was calculated to be 10.3 Ǻ. In ergosterol-containing POPC MLVs, the 
calculated distance increased to 12.1 Ǻ. The authors concluded that ergosterol increases the 
distance between adjacent AmB molecules in the channel complex. In contrast to the model 
proposed in their study of the F-erg-AmB conjugate, it was now proposed that ergosterol does 
intercalate between adjacent AmB molecules.    
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A 2H-NMR study45 of a deuterated AmB derivative, AmB-d6 1.13 and deuterated sterols 
ergosterol-d1 1.14 and cholesterol-d1 1.15 further supported a model in which AmB interacts 
more closely with ergosterol than with cholesterol. This study was based on the work of 
Dufourc46 showing that the 2H spectrum of cholesterol-d1 was not significantly perturbed by 
AmB. Murata and coworkers performed similar experiments on cholesterol-d1 and ergosterol-d1 
in POPC MLVs in the presence of increasing amounts of AmB. Conversely, the spectrum of 
14 
AmB-d6, was analyzed for the same series of AmB/ergosterol ratios. Deuterium powder spectra 
for each molecule were analyzed for changes in the presence of AmB. The cholesterol-d1 
spectrum was not substantially perturbed by AmB, whereas the spectrum of ergosterol-d1 
coalesced toward the isotropic center peak. It was concluded that the fast axial diffusion of 
ergosterol was inhibited by AmB. Based on the spectra of AmB-d6, it was concluded that AmB is 
also immobilized under the same conditions. From the similar mobility of AmB and ergosterol, it 
was concluded that these two molecules have a direct interaction in POPC vesicles. Lack of 
perturbation of the cholesterol-d1 spectrum led the authors to conclude that AmB has a weaker 
intermolecular interaction with cholesterol. Importantly, in other studies Murata and coworkers 
concluded that AmB does not bind cholesterol.47  In addition, it had remained controversial 
whether AmB binds directly to ergosterol3,12,27,30,31,32,42,45,48,49,50,51 or whether AmB's sterol-
dependence was an indirect consequence of membrane sterol content,47,52,53,54,55,56,57,58,59,60 and 
Baginski recently reported47 that this issue remained unresolved. 
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 The Murata group also recently reported 13C-19F REDOR studies of 14-fluoro-AmB and 
a skipped 13C-labeled ergosterol (1.16, Figure 1-11) in POPC MLVs.48 These experiments 
revealed dephasing of ergosterol C19, C21, C26, and C27 in the presence of 14-fluoro-AmB. In 
addition, 13C-31P REDOR revealed dephasing of ergosterol C26 and C27 by 31P of POPC. 
Viewed through the lens of the leading ion channel model for the mechanism of action of AmB 
and the previously described REDOR studies in saturated lipids, it was concluded based on these 
latest REDOR results that the AmB ion channel is comprised of both “head-to-head” and “head-
to-tail” orientation of AmB and ergosterol.  Importantly, however, the 13C-31P REDOR 
experiments that were previously performed in saturated lipids devoid of ergosterol were not 
repeated in this POPC-based system. Also significantly, to the best of our knowledge, direct 13C-
31P REDOR dephasing between AmB and POPC or any other unsaturated lipid has not been 
reported. 
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Figure 1-11. Shown at right is the skipped 13C-labeled ergosterol used for 13C-19F REDOR experiments. At left, 
green spheres indicate nuclei dephased by 19F. The authors proposed both head-to-tail and head-to-head interactions 
of AmB with ergosterol. 
As described above, we recognized limitations with the aforementioned studies that 
complicated interpretation of the reported results. Most importantly, no functional validation of 
the liposome system was reported. In particular, the MLVs composed of saturated lipids (DMPC, 
DLPC, DSPC) contained no sterol. The functional relevance of studying AmB in this type of 
system remains controversial. As will be described in chapter 3, POPC/AmB/Ergosterol MLVs 
have been found to be a physiologically relevant bilayer system. However, interpreting the above 
data through the lens of the prior studies with saturated lipids complicates collective data 
interpretation. Moreover, as will be described in chapter 3, studies from our group have revealed 
that AmB primarily kills yeast by simply binding ergosterol – channel formation is actually not 
required. 
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1-8 SUMMARY 
For nearly 40 years, two hypotheses have been the driving force for experiments probing 
the activity of AmB: 1) AmB primarily inserts in membranes to form discrete ion channel pores, 
and 2) these ion channel pores are stabilized primarily by a ring of polar interactions between the 
C41 carboxylate and the C3' amine. This dissertation describes experiments that test both of 
these hypotheses. We have developed an alternative to the covalent modification strategy for 
studying the functional groups of AmB which involves synthetically deleting the functional 
group in question, determining the conformation of the resulting compound, and determining the 
biophysical and biological consequences of this deletion. This method is analagous to the protein 
technique of alanine scanning which determines the functional role of individual amino acids by 
systematically replacing them with alanine. In this type of an approach, conformational analysis 
is critical to rule out the possibility that conformational changes are responsible for observed 
changes in function.  
Applying this functional group deletion strategy to AmB, we synthesized C41-methyl 
amphotericin B, amphoteronolide B, and C41-methyl amphoteronolide B (1.7 through 1.9) 
lacking either one (1.7 and 1.8) or both (1.9) of the functional groups predicted to be critical for 
stabilizing the amphotericin B ion channel. In stark contrast to the leading hypothesis of AmB 
antifungal activity, C41-methyl AmB, which lacks the capacity to form the predicted ring of 
channel stabilizing polar interactions, is equipotent to the natural product. This work will be 
detailed in Chapter 2.  
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Moreover, we have developed a SSNMR method for probing the primary location of 
AmB in phospholipid bilayers using paramagnetic spin-labeled phospholipids. These 
paramagnetic probe reagents have a dramatic impact on T1 relaxation of POPC 13C nuclei. 
Strikingly, no such perturbation was observed for AmB 13C nuclei, indicating that the majority of 
AmB is not localized within the phospholipid bilayer. Moreover, additional experiments have 
revealed that extramembranous aggregates of AmB extract ergosterol from bilayer membranes, 
providing both a structural and functional foundation for our observations that sterol binding is in 
17 
fact the primary mechanism by which AmB kills yeast. This work will be detailed in Chapters 3 
and 4.  
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CHAPTER 2 
Degradative synthesis, NMR conformational analysis, and evaluation of antifungal activity 
of C41-methyl amphotericin B, amphoteronolide B, and C41-methyl amphoteronolide B 
 
ABSTRACT 
As discussed in Chapter 1, past efforts toward understanding the structure/function 
relationships underlying the AmB ion channel have focused on covalent modification of the 
natural product. An alternative strategy developed in our group is to synthetically delete protic 
functional groups from the AmB skeleton and determine the functional consequences. This 
strategy circumvents the inherent shortcomings of the covalent modification approach since no 
steric bulk is added to the molecular scaffold and these derivatives lack the ability to hydrogen 
bond at the site of deletion. However, a new consideration is introduced by this functional group 
deletion approach–conformation of the macrolide skeleton. While it has been demonstrated that 
AmB derivatives with covalent modifications of the carboxylic acid or amine functional groups 
have the same ground-state conformation as judged by NMR1 or X-ray crystallographic2 
analysis, respectively, the effect of functional group deletion on AmB conformation has not been 
studied. To address this question, we have employed Monte Carlo methods constrained by 
phase-sensitive COSY and NOESY NMR data to determine the conformations of AmB, C41-
methyl amphoteronolide B, amphoteronolide B, and C41-methyl amphotericin B. Through this 
approach we have demonstrated that the conformation of the AmB macrolactone remains 
unchanged upon deletion of appended functional groups. Thus, our conformational analysis has 
enabled the unambiguous interpretation of functional data obtained for these derivatives, leading 
to the striking observation that, contrary to the current channel model, oxidation at C41 is not 
required for potent antifungal activity. 
Daniel Palacios optimized conditions for reduction of the C41 carboxyl group to the 
corresponding C41 methyl, developed the flexible synthetic pathway to 2.2-2.4, and contributed 
to preliminary NMR conformational analysis studies. Portions of this chapter are taken with 
permission from Palacios, D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc. 2007, 129, 
13804-13805. 
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2-1 SYNTHESIS OF AMPHOTERICIN DERIVATIVES 
Manipulation of AmB is challenging due to its light, oxygen, and acid sensitivity as well 
as its poor solubility in water and most common organic solvents. Nevertheless, we have 
developed a flexible, modular synthesis which allows for reversal of either3 one or both of the 
two post-PKS modifications predicted to be critical for self-assembly of the AmB ion channel. 
The two key transformations in this synthesis are reduction of the C41 carboxyl group to the 
corresponding methyl and oxidative removal of the mycosamine sugar. Conditions for reduction 
of the C41 carboxylic acid and oxidative deglycosidation of the amphotericin B macrolide were 
optimized in the context of degradative syntheses of C41-methyl AmB 2.4 and amphoteronolide 
B 2.3, respectively. 
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Our first synthesis of amphoteronolide B (Scheme 2.1) built on the degradative synthesis 
reported by Nicolaou.3a For the key deglycosidation reaction, we opted for Masamune’s higher-
yielding deglycosidation4 under the action of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
(DDQ). However, several problems were encountered which rendered this synthetic route 
infeasible for synthesis of 2.3 in quantities sufficient for the intended assays and NMR studies.  
The primary difficulty was the sensitive nature of the trimethylsilyl protected intermediate 2.6, 
which did not tolerate reaction conditions of the oxidative deglycosidation to enone 2.7 (TLC of 
the reaction mixture indicated formation of numerous inseparable byproducts).  Purification of 
2.7 by flash chromatography proved excessively challenging, presumably due to the acid-labile 
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nature of the trimethylsilyl protecting group.  Both Masamune’s and Nicolaou’s conditions 
resulted in prohibitively low yields (<15%) for this key transformation.  
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Scheme 2.1 1st generation synthesis of amphoteronolide B 
 Faced with these challenges, we devised a synthesis that would provide a more robust, 
high-yielding deglycosidation.  Noting that Masamune’s substrate for the deglycosidation 
contained tert-butyldimethylsilyl (TBDMS) and acetonide protecting groups, and that 
MacPherson et al.3c chose triethylsilyl protecting groups for degradative syntheses of AmB 
derivatives, the more robust triethylsilyl group was chosen for our studies.  
The second-generation synthesis of amphoteronolide B (Scheme 2.2) proceeded via 
protection of the C3' amine as the corresponding 9-(fluoreneyl)-methoxycarbonyl (Fmoc) 
carbamate followed by protection of the anomeric hydroxyl as a methyl ketal. Protection of the 
C41 carboxyl as an allyl ester and global triethylsilyl (TES) hydroxyl protection yielded the 
deglycosidation precursor 2.10.  
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Scheme 2.2. Second generation synthesis of allyl heptaenone intermediate en route to amphoteronolide B 
A screen of reaction conditions for deglycosidation of 10 revealed a strong temperature 
dependence for conversion to heptaenone 2.11.  Surprisingly, at -78 ºC, 58% starting material 
was recovered, while 5% of the desired enone was isolated (Table 2-1, entry 1).  Repeating the 
reaction at 0 ºC (entries 2-4) and room temperature (entries 5-6) resulted in higher isolated yields 
of 2.11, with reproducible yields at room temperature between 55-60%  This represents the 
highest yield ever reported for deglycosidation of an amphotericin derivative to the 
corresponding heptaenone.3a, 4   
Entry DDQ eq Temperature Time Yield Recovered Starting Material 
1 0.95 -78 °C 25 min 5% 58% 
2 0.95 0 °C 30 min 49% 24% 
3 1.5 0 °C 10 min 48% 18% 
4 1.5 0 °C 50 min 48% - 
5 1.5 23 ºC 60 min 59% - 
6 1.5 23 ºC 55 min 57% - 
Table 2-1. Optimization of conditions for DDQ-mediated oxidative deglycosidation of 10. 
 
With the enone in hand, amphoteronolide B was accessible via four deprotection steps 
(Scheme 2.3).  NaBH4 reduction of 11 proceeded in 78% yield followed by desilylation to form 
2.12 as a single diastereomer3a in 84% yield.  The methyl ketal 2.12 was hydrolyzed in 76% 
yield, and Pd-mediated deallylation yielded amphoteronolide B in 16% yield after HPLC 
purification. The optimized deglycosidation conditions were incorporated by Dan Palacios into a 
flexible synthetic pathway which afforded 2.2-2.4 in quantities and purities sufficient for 
antifungal assays (>10 mg of each compound was obtained in >90% purity as measured by 
HPLC).5 
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Scheme 2.3. Second generation synthesis of amphoteronolide B. 
2-2 NMR-BASED CONFORMATIONAL ANALYSIS 
 Conformational analysis of 2.1-2.4 was critical for enabling interpretation of functional 
data generated by biophysical assays of these derivatives. Because the AmB macrolactone is 
known to be rigid,1 we hypothesized that the ground-state conformation would be unchanged by 
these functional group deletions. To test our hypothesis, we employed Monte Carlo methods 
constrained by phase-sensitive COSY (COSYPS) and NOESY NMR data to determine the 
solution conformation of 2.1-2.4. Compounds 2.1, 2.3, and 2.4 were not amenable to high 
resolution solution NMR analysis due to their poor solubilities in appropriate NMR solvents. 
Therefore, we chose the suitably protected analogs N-acyl AmB methyl ester 2.13,3a AmdeB 
allyl ester 2.14, and N-Fmoc MeAmB 2.15 for the conformational analysis of 2.1, 2.3, and 2.4, 
respectively. MeAmdeB 2.2 was used directly in our NMR studies.  
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To obtain dihedral constraints for conformational analysis, coupling constants for each 
compound were extracted from COSYPS spectra using amplitude-constrained multiplet 
evaluation (ACME) in nmrPipe.6 The ACME method for determining J values from COSYPS 
spectra is described in detail by Delaglio et al.6b Briefly, nmrPipe can accurately model the 
crosspeaks of a COSYPS spectrum provided the spectrum is acquired with interscan delay time 
sufficient for the spins to fully relax. A peak-fitting algorithm fits spectrum crosspeaks and 
calculates coupling constants for the corresponding spins. 
Raw COSYPS data were acquired and processed as described by Delaglio6b to produce a 
diagonal-suppressed spectrum7 and a diagonal-only spectrum (Figure 2-1 depicts representative 
spectra for the AmdeB allyl ester 2.14). ACME integrates selected peaks from the diagonal-only 
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spectrum and the average integration value is used for peak-fitting of crosspeaks in the diagonal-
suppressed spectrum. Figure 2-2 shows the results of fitting two peaks from the COSYPS 
diagonal of AmdeB allyl ester 2.15. Panels A, B, and C contain; A) the selected region of the 
spectrum (with peaks for fitting labeled 1 and 2), B) simulated peaks calculated in the fitting 
process, C) the residual between the experimental and calculated peaks. Therefore, in an accurate 
simulation, no residual is present for the selected peaks. Through this process, the average 
integration of diagonal peaks can be applied to peak-fitting of crosspeaks in the diagonal-
suppressed spectrum. 
 
Figure 2-1. A. Diagonal-only COSYPS spectrum of AmdeB allyl ester 2.14. B. Diagonal-only COSYPS spectrum of 2.14. 
Adapted with permission from Palacios, D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-13805. 
Copyright 2007 American Chemical Society. 
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Figure 2-2. ACME results for fitting the AmdeB allyl ester 2.14 diagonal. A. The selected spectral region with peaks for fitting 
labeled 1 and 2. B. Simulated peaks calculated in fitting process. C. Residual between panels A) and B). Adapted with 
permission from Palacios, D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-13805. Copyright 2007 
American Chemical Society. 
The fine structure of crosspeaks in a COSYPS spectrum provides coupling constant data8 
in a manner analogous to obtaining coupling constants from a one-dimensional multiplet. In a 
two-dimensional crosspeak, the spacing between antiphase portions of the crosspeak corresponds 
to the J value for the associated spins. The ACME method employs the reference integration 
from the diagonal in a peak-fitting algorithm that fits selected crosspeaks and calculates coupling 
constants. Figure 2-3 shows the results of the fitting algorithm applied to the cross-peak 
corresponding to protons H-18 and H-17 in AmdeB allyl ester 2.14. Panel A again contains the 
selected peak from the spectrum, Panel B depicts the simulated crosspeak, and Panel C displays 
the residual. The lack of any significant residual is consistent with accurate reproduction of the 
multiplet fine structure in the fitting process. Similar analysis for each crosspeak in the spectra of 
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compounds 2.2, 2.13, 2.14, and 2.15 was used to derive the coupling constants from which 
dihedral constraints were calculated (see Table 2-2 for a compilation of these data). 
 
Figure 2-3. Calculation of 3J for H-18a (pseudoaxial) and H-17 for AmdeB allyl ester 2.21. ACME accurately reproduces the 
fine structure of the multiplet with no residual between the experimental and calculated peaks. Adapted with permission from 
Palacios, D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-13805. Copyright 2007 American Chemical 
Society. 
Dihedral angles were calculated from 1H-1H 3J values according to Altona’s extended 
Karplus9 equation using the MestReJ software.10 However, each 3J gives rise to 4 possible 
solutions to the Karplus equation. Methods for choosing the appropriate value are well-
precedented. For example, in the context of conformational analysis of the erythronolide B 
lactone, Aurichio11 and Egan12 chose dihedral values consistent with NOE data and the 
erythronolide B crystal structure, respectively. For our analyses, we chose angles consistent with 
both NOESY data and the AmB crystal structure.2 In some cases, two solutions to the Karplus 
equation were consistent with both NOESY and crystal structure data, and both solutions were 
included. 
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Consistent with protein structural analysis techniques,8 each H-H dihedral was 
constrained to the selected value ± 30º. When two solutions to the Karplus equation were 
selected, both values (± 30º) were allowed. Table 2-2 lists the J values and corresponding 
dihedral constraints used in the conformational searching. Consistent with the known trans-
configuration of the seven double bonds of the polyene moiety,2 the π-bonds were constrained to 
180º ± 10°.Interproton distances were constrained for proton pairs exhibiting NOE correlations, 
with the lower limit set at 1.8 Å (twice the hydrogen van der Waals radius), and the upper limit 
set at 5.0 Å.8 Table 2-3 lists the NOE correlations used for conformational searching, and Figures 
2-4 through 2-7 depict these correlations (red lines indicate NOE correlations). Notably, all four 
compounds contain a series of transannular NOEs between protons of the polyol and those of the 
polyene. 
All NMR-derived distance and dihedral constraints were enforced in Monte Carlo 
conformational searches. This type of conformational search probes conformational space by 
randomly perturbing all dihedral angles in the molecule and then minimizing the resulting 
structures (with constraints enforced). Conformational searches were performed using the 
Molecular Operating Environment program (MOE),13 with an empirical MMFF94x force field 
and a Born solvation model.  3500 conformations were generated and minimized for each 
compound, and each lowest energy conformation was used for root-mean-square (RMS) atom 
alignment of the four macrolactone rings. 
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Table 2-2. Dihedral constraints used in conformational searches using MOE. Also shown are the coupling constants (calculated 
by ACME) from which the dihedral constraints were derived. See supporting information for a description of the axial (ax) and 
equatorial (eq) convention for AmB. Adapted with permission from Palacios, D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. 
Soc.  2007, 129, 13804-13805. Copyright 2007 American Chemical Society. 
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Table 2-3. Observed NOE correlations used to derive distance constraints in conformational searches using MOE. Adapted with 
permission from Palacios, D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-13805. Copyright 2007 
American Chemical Society. 
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Figure 2-4. NOE correlations for N-acyl AmB Methyl ester 2.13. For clarity, appendages other than protons have 
been removed from the macrolide skeleton. Selected carbon atoms are numbered. Adapted with permission from 
Palacios, D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-13805. Copyright 2007 
American Chemical Society. 
 
 
 
Figure 2-5. NOE correlations for MeAmdeB 2.2. For clarity, appendages other than protons have been removed 
from the macrolide skeleton. Selected carbon atoms are numbered. Adapted with permission from Palacios, D.S.; 
Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-13805. Copyright 2007 American Chemical 
Society. 
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Figure 2-6. NOE correlations for AmdeB allyl ester 2.14. For clarity, appendages other than protons have been 
removed from the macrolide skeleton. Selected carbon atoms are numbered. Adapted with permission from Palacios, 
D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-13805. Copyright 2007 American 
Chemical Society. 
 
 
Figure 2-7. NOE correlations for N-Fmoc MeAmB 2.15. For clarity, appendages other than protons have been 
removed from the macrolide skeleton. Selected carbon atoms are numbered. Adapted with permission from Palacios, 
D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-13805. Copyright 2007 American 
Chemical Society. 
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Only the atoms of the macrolactone ring and the cyclic hemiketal were used for RMS 
alignment. All other atoms were deleted from the lowest-energy conformers and the four 
resulting macrolide skeletons representing the ground-state conformations of AmB 2.1, MeAmB 
2.2, AmdeB 2.3, and MeAmdeB 2.4 were used for alignment. Rigid RMS atom alignment 
revealed RMS deviation (RMSD) of 0.081 Å for the four structures (Figure 2-8). Thus, 
functional group deletion does not change the conformation of the AmB macrolide skeleton. 
 
Figure 2-8. Superposition of the ground-state conformation of the macrolactone 
skeletons of compounds 2.1 - 2.4 (or their more soluble analogs). Rigid RMS atom 
alignment revealed RMSD = 0.081 Å for the four structures. Adapted with permission 
from Palacios, D.S.; Anderson, T.M.; Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-
13805. Copyright 2007 American Chemical Society. 
 
2-3 ANTIFUNGAL ASSAYS 
The impact of our functional group deletions on antifungal activity was evaluated in a 
disc diffusion assay14 of each compound against Saccharomyces cerevisiae. As shown in Figure 
2-9, MeAmdeB 2.2 and AmdeB 2.3 were inactive. In contrast, and contrary to the current 
channel model for AmB antifungal activity, MeAmB 2.4 was found to possess activity similar to 
AmB. This result was confirmed quantitatively in a broth dilution assay15 to determine the 
minimum inhibitory concentration (MIC) for each compound (Figure 2-9). Similar results were 
observed in both assays for the clinically relevant yeast Candida albicans (see supporting 
information for full details). Because each compound occupies the same conformation, these 
results cannot be attributed to conformational changes. Clearly, oxidation at C41 is not required 
for potent antifungal activity. 
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Figure 2-9. (A) Disc diffusion assay with S. cerevisiae (40 μg of compound per disc). Similar results were achieved with C. 
albicans. (Supporting Information). (B) Broth dilution assays.  Adapted with permission from Palacios, D.S.; Anderson, T.M.; 
Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-13805. Copyright 2007 American Chemical Society. 
2-4 DISCUSSION 
The work described in this chapter demonstrates a new approach for studying AmB 
structure/function relationships via functional group deletion and studying the functional 
consequences of each deletion. Solution NMR conformational analysis directly enabled 
unambiguous interpretation of our functional studies of 2.2, 2.3, and 2.4. Having determined that 
functional group deletion did not change the conformation of the macrolactone, we were 
confident that the observed changes in function were a direct result of functional group deletion.   
Systematic application of the functional group deletion strategy is currently underway in our 
laboratories to dissect the structure/function 
relationships underlying the activity of AmB. 
Most notably, Kaitlyn Gray et al.25 have applied 
the functional group deletion strategy to 
synthesize C35-deoxy-AmB (2.16) and study its 
biophysical properties.  
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The discoveries presented in this chapter strongly contradict the current model for AmB 
antifungal activity – salt bridge stabilization is not required for AmB antifungal activity. There 
are at least two possible explanations for this phenomenon. Oxidation at C41 may not be 
required for channel activity and/or channel activity may not be required for antifungal activity. 
To address the first of these possibilities, extensive biophysical studies of 2.1-2.4 performed in 
our laboratories by Daniel Palacios et al.26 have confirmed that C41-methyl amphotericin B 2.4 
retains full channel and activity while amphoteronolide B 2.3 and C41-methyl amphoteronolide 
B 2.2 have no channel activity in liposome K efflux and planar lipid bilayer assays. Thus, 
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oxidation at C41 is not required for AmB channel activity. The work of Kaitlyn Gray et al.25 on 
C-35-deoxy-AmB addressed the second possibility. C-35-deoxy AmB was found to have no 
channel activity while retaining potent antifungal activity against S. cerevisiae and C. albicans. 
Thus, channel activity is not required for antifungal activity. These studies and their impact on 
the experiments described in this dissertation will be discussed further in Chapter 3.       
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2-5 EXPERIMENTAL SECTION 
Part 1. General Methods 
Materials.  Commercially available materials were purchased from Aldrich Chemical Co. 
(Milwaukee, WI), Fisher Scientific (Hampton, NH), Lipoid (Luwigshafen, Germany) and 
Silicycle (Quebec, Canada) and used without further purification unless noted otherwise.  
Amphotericin B was a generous gift from Bristol-Myers Squibb Company.  All solvents were 
dispensed from a solvent purification system that passes solvents through packed columns 
according to the method of Pangborn and coworkers16 (THF, Et2O, CH2Cl2 : dry neutral alumina; 
DMSO, DMF, CH3OH : activated molecular sieves).  Hexanes, 2,6-lutidine, triethylamine, and 
pyridine were freshly distilled under nitrogen from CaH2. Camphorsulfonic acid was 
recrystallized from ethyl acetate.  Water was doubly distilled or obtained from a Millipore 
(Billerica, MA) Gradient A10 MilliQ water purification system. 
Reactions. Due to the light and air sensitivity of amphotericin B, all manipulations were carried 
out under low light conditions and compounds were stored under an anaerobic atmosphere. All 
reactions were performed in oven- or flame-dried glassware under an atmosphere of argon unless 
otherwise indicated.  Reactions were monitored by analytical thin layer chromatography 
performed using the indicated solvent on E. Merck silica gel 60 F254 plates (0.25mm).  
Compounds were visualized using a UV (λ254) lamp or stained by an acidic solution of p-
anisaldehyde.  Alternatively, reactions were monitored by RP-HPLC using an Agilent 1100 
Series HPLC system equipped with a SunfireTM C18 5 micron 10 x 250 mm column (Waters 
Corp. Milford, MA) with UV detection at 406 nm and the indicated eluent and flow rate. 
Purification and Analysis.  Flash chromatography was performed as described by Still and 
coworkers16 using the indicated solvent on E. Merck silica gel 60 230-400 mesh or on Silicycle 
17% carbon C18 230-400 mesh reverse phase silica gel.  1H NMR spectra were recorded at 23 °C 
on a Varian Unity Inova Narrow Bore spectrometer operating at a 1H frequency of 500 MHz 
with a Varian 5 mm 1H{13C/15N} pulsed-field gradient Z probe or a Varian Unity Inova 
spectrometer operating at a 1H frequency of 600 MHz with a Varian 5 mm 1H{13C/15N} pulsed-
field gradient X,Y,Z probe. Chemical shifts (δ) are reported in parts per million (ppm) downfield 
from tetramethylsilane and referenced internally to the residual protium in the NMR solvent 
(CHD2OD, δ = 3.31, center line, CD3C(O)CHD2, δ = 2.05, center line) or to added 
tetramethylsilane.  Data are reported as follows: chemical shift, multiplicity (s = singlet, d = 
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doublet, t = triplet, dd = doublet of doublets, m = multiplet, b = broad, app = apparent), coupling 
constant (J) in Hertz (Hz) and integration. For compounds 2.13 (a more soluble derivative of 
2.1), 2.2, 2.14 (a more soluble derivative of 2.3), and 2.15 (a more soluble derivative of 2.4), 
proton and coupling constant assigments were made using a variety of two-dimensional NMR 
techniques including phase-sensitive COSY experiments combined with amplitude constrained 
multiplet evaluation (ACME)6b (see Part III for a detailed discussion). 13C spectra were recorded 
at 23 °C with a Varian Unity Inova spectrometer operating at a 13C frequency of 125 MHz with a 
5 mm Nalorac gradient {13C/15N}1H quad probe or a Varian Unity Inova spectrometer operating 
at a 13C frequency of 150 MHz and equipped with a Varian 5 mm 600 DB Auto X probe. 
Chemical shifts (δ) are reported downfield of tetramethylsilane and are referenced to the carbon 
resonances in the NMR solvent (CD3OD, δ = 49.0, center line, CD3C(O)CD3, δ = 29.8, center 
line) or to added tetramethylsilane (δ = 0.00). MS analysis was performed with an Applied 
Biosystems Micromass Ultima system with ESI ionization.  High resolution mass spectra 
(HRMS) were obtained at the University of Illinois mass spectrometry facility.  All synthesized 
compounds gave HRMS within 5 ppm of the calculated values. The purity of amphotericin B and 
its derivatives was determined by HPLC analysis using a Waters SunFire Prep C18 OBD 5 
micron 30 x 150 mm Lot # 168I161701 column with detection at 406 nm and an eluent of 
acetonitrile and aqueous ammonium acetate unless otherwise indicated. 
Part 2. Synthesis of AmB derivatives 
 
13-O-Methyl N-Fmoc Amphotericin B (2.9) 
The following procedure was followed twice in parallel:  Amphotericin B (1.5 g, 1.46 mmol) 
was dissolved in a mixture of DMF (70 mL) and methanol (35 mL) in a round-bottom flask with 
magnetic stirring under argon in the dark.  Pyridine (840 μL, 10.22 mmol, freshly distilled over 
CaH2) was added followed by N-(9-fluorenylmethoxycarbonyl)oxysuccinimide (840 mg, 2.48 
mmol).  The resulting solution was stirred for 13 hours at which point the reaction flask was 
poured into 1.8 L cold (0 °C) diethyl ether.  The resulting yellow precipitate was stirred at 0 °C 
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for 30 minutes.  The precipitate from both reaction flasks was collected by vacuum filtration.  
The filter cake was washed with cold diethyl ether, collected, and placed under high vacuum 
overnight.  The yellow N-Fmoc amphotericin B (2.84 g, 2.5 mmol) was dissolved in 1:1 
THF/Methanol (84 mL) in a round-bottom flask with magnetic stirring under argon in the dark.  
The reaction flask was cooled to 0 °C, (±)-10-camphorsulfonic acid (174 mg, 0.75 mmol) was 
added, and the reaction was stirred for 1 hour at 0 °C.  Triethylamine (105 μL, 0.75 mmol) was 
added and the flask contents were filtered through filter paper to remove precipitated salt.  The 
solution was concentrated in vacuo until precipitate began to form, at which point flask contents 
were poured into 800 mL 1:1 hexanes/diethyl ether, rinsing the flask with a small amount of 1:1 
THF/diethyl ether.  The resulting yellow precipitate was filtered and washed with 1:1 diethyl 
ether/ethyl acetate (250 mL).  The filter cake was collected and placed under high vacuum 
overnight to furnish 2.9 as a yellow solid (3.04 g, 2.6 mmol, 90% from 2.1) which was used 
without further purification.   
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1H NMR (400 MHz, DMSO d-5), selected resonances 
δ 7.88 (d, J = 7.6 Hz, 2H), 7.76 (dd, J = 2.8, 4.4 Hz, 2H), 7.41 (t, J = 7.6 Hz, 2H), 7.32 
(dd, J = 4.8, 7.2 Hz, 2H), 6.49-5.84 (m, 13H), 5.42 (dd, J = 4, 10.4 Hz, 1H), 5.19 (app d, 
J = 4.4 Hz, 1H), 4.82 (app t, J = 6.4 Hz, 3H), 4.77 (d, J = 4 Hz, 1H), 4.67 (m, 2H), 4.45 
(d, J = 6 Hz, 1H), 4.21 (app t, J = 8.8 Hz, 1H), 4.10-3.92 (m, 2H), 3.58 (m, 1H), 3.55-
3.30 (m, 5H), 3.21-3.01 (m, 4H), 2.35-2.21 (m, 1H), 2.14 (app d, J = 5.6 Hz, 2H), 1.96 (t, 
J = 11 Hz, 2H), 1.86 (d, J = 8 Hz, 1H), 1.70 (d, J = 6.8 Hz, 1H), 1.65-1.19 (m, 10H), 1.15 
(d, J = 4.8 Hz, 3H), 1.09 (d, J = 6.0 Hz, 3H), 1.02 (d, J = 6.0 Hz, 3H), 0.90 (d, J = 7.2 Hz, 
3H). 
HRMS (ESI) 
calculated for C63H85NO19 (M + Na)+: 1182.5614 
found: .      1182.5608 
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13-O-Methyl N-Fmoc Amphotericin B Allyl Ester (2.17) 
Compound 2.9 (1.69 g, 1.46 mmol) was dissolved in 50 mL DMF with magnetic stirring under 
argon in the dark.  Methanol (5 mL), Hunig’s base (1 mL, 5.9 mmol), and allyl bromide (5 mL, 
58 mmol) were added sequentially and the reaction was stirred for 4 hours, at which point the 
flask contents were poured into 2:1 hexanes/diethyl ether (1.8 L).  A yellow-brown precipitate 
formed and settled to the bottom of the Erlenmeyer flask, and the hexanes/diethyl ether is 
removed via vacuum filtration.  The precipitate (still on the bottom of the Erlenmeyer flask) was 
dissolved in a minimum amount of 1:1 THF/Methanol.  The filter paper from the vacuum 
filtration was rinsed with 1:1 THF/Methanol and the combined crude product was concentrated 
in vacuo to a yellow-brown solid which was washed with water and gravity filtered through 
fluted filter paper.  The solid was collected and coevaporated twice with acetonitrile.  The crude 
solid was purified by flash chromatography (SiO2, 10% methanol/methylene chloride) to yield 
2.17 (1.275 g, 1.06 mmol, 73%) as a yellow solid.   
O
O
O
O
OH
CO2Allyl
Me
Me
Me
HO OH OH
OH
OH OH
O
NHFmoc
Me
HO OH
OMe
H
2.17
 
TLC (CH2Cl2:MeOH 9:1) 
Rf = 0.4, stained by p-anisaldehyde 
 
1H NMR (400 MHz, CD3OD), selected resonances 
δ 7.82 (d, J = 7.6 Hz, 2H), 7.68 (dd, J = 3.2, 4 Hz, 2H), 7.39 (t, J = 7.4 Hz, 2H), 7.31 (app 
t, J = 7.4 Hz, 2H), 6.44-6.10 (m, 12H), 6.97 (ddd, J = 5.6, 11.2, 16.4 Hz, 1H), 6.85 (dd, J 
= 6.4, 15.2 Hz, 1H), 5.49 (dd, J = 9.6, 14 Hz, 1H), 5.40 (dd, J = 1,2, 16.8 Hz, 1H), 5.26 
(app d, J = 10.9 Hz, 1H), 5.19 (app t, J = 5.2 Hz, 1H), 4.67 (app ddd, J = 6, 13.2, 19.2 
Hz, 2H), 4.57 (app t, J = 7.2 Hz, 1H), 4.50 (s, 1H), 4.36 (d, J = 6.8 Hz, 2H), 4.23 (t, J = 
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6.8 Hz, 1H), 4.20-4.09 (m, 2H), 4.00 (t, J = 9.2 Hz, 1H), 3.93 (m, 1H), 3.79 (d, J = 2.8 
Hz, 1H), 3.70 (m, 1H), 3.58 (app dd, J= 3.0, 9.8 Hz, 1H), 3.50 (app dd, J = 1.4, 8.6 Hz, 
1H), 3.34 (s, 1H), 3.23-3.15 (m, 4H), 2.42-2.15 (m, 5H), 2.00 (m, 1H), 1.90-1.78 (m, 2H), 
1.76-1.52 (m, 5H), 1.52-1.31 (m, 7H), 1.27 (d, J = 5.2 Hz, 3H), 1.19 (d, J = 6.4 Hz, 3H), 
1.10 (d, J = 6.4 Hz, 3H), 1.00 (d, J = 6.8 Hz, 3H) 
 
HRMS (ESI)  
calculated for C66H89NO19 (M + Na)+:   1222.5927 
found:        1222.5876 
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Nonakis-triethylsilyl 13-O-Methyl-N-Fmoc Amphotericin B Allyl Ester (2.10) 
Compound 2.17 (535 mg, 0.45 mmol) was suspended in hexanes (15 mL, freshly distilled over 
CaH2) with magnetic stirring under argon in the dark.  The reaction flask was cooled to 0 °C, and 
2,6-lutidine (0.94 mL, 8.1 mmol, freshly distilled over CaH2) was added, followed by 
triethylsilyl trifluoromethanesulfonate (1.43 mL, 6.3 mmol, added dropwise), and the reaction 
was stirred for 2 hours at 0 °C.  After two hours, 2,6-lutidine (0.47 ml, 4 mmol, freshly distilled 
over CaH2) and triethylsilyl trifluoromethanesulfonate (0.72 mL, 3.15 mmol, added dropwise) 
were added.  Fifteen minutes after completion of this addition, 2,6-lutidine (0.47 mL, 4 mmol, 
freshly distilled over CaH2) and triethylsilyl trifluoromethanesulfonate (0.72 mL, 3.15 mmol, 
added dropwise) were added and the reaction was stirred for one more hour.  The reaction was 
quenched by addition of saturated aqueous NaHCO3 (~50 mL) and flask contents were 
transfeered to a separatory funnel containing saturated aqueous NaHCO3 (~300 mL).  Diethyl 
ether (~300 mL) was added to the separatory funnel and the crude product was partitioned 
between the organic and aqueous layers.  The organic layer was washed with water (3 x 300 
mL), saturated aqueous CuSO4 (2 x 300 mL), and brine (1 x 300 mL).  The organic layer was 
dried over anhydrous Na2SO4, gravity filtered through fluted filter paper, and concentrated in 
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vacuo to yield a viscous yellow-orange oil (still containing triethylsilanol).  This oil was 
coevaporated with toluene overnight under high vacuum.  A second coevaporation with toluene 
was performed before purification of the crude oil by flash chromatography (SiO2, 10% to 25% 
Ether/Hexanes) to yield 2.10 as a yellow oil (517 mg, 0.23 mmol, 52%).  
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TLC (Petroleum ether:diethyl ether 4:1) 
Rf = 0.6, stained by p-anisaldehyde 
 
1H NMR (Acetone-d6, 500 MHz)   
δ 7.64 (d, J = 7.5 Hz, 2H, Fmoc–H), 7.69, (d, J = 7 Hz, 2H, Fmoc-H), 7.42, (t, J = 7.5 
Hz, 2H, Fmoc–H), 7.34 (tq, J = 7 Hz, 1 Hz, 2H, Fmoc-H), 6.56-6.11 (m, 12H, H-21 
through H-32), 6.06-5.94 (m, 2H, H-20, H-43), 5.49 (dd, J = 9.5, 15 Hz, 1H, H-33), 5.44 
(app dd, J = 1.5, 17 Hz, 1H, Allyl-H), 5.35 (d, J = 10 Hz, 1H), 5.29 (dd, J = 1.5, 10 Hz, 
1H, Allyl H), 4.76-4.58 (m, 4H, Allyl-CH2, H-37, H-19), 4.51-4.41 (m, 2H, H-15, 
Fmoc-H), 4.47 (app s, 1H, H-1'), 4.33 (dd, J = 7.5, 10.5 Hz, 1H,Fmoc–H), 4.26-4.12 (m, 
2H), 4.12 (m, 1H), 3.99 (m, 2H,  H-17, one unassigned), 3.90 (d, J = 3 Hz, 1H, H-2'), 
3,84 (dd, J = 2.5, 9 Hz, 1H, H-35), 3.66 (m, 2H, H-3', one unassigned), 3.45 (t, J = 9 Hz, 
1H, H-4'), 3.30 (m, 1H, H-5'), 3.13 (s, C13-OMe), 2.79 (d, J = 16.5 Hz, 1H), 2.57 (app 
d, J = 7 Hz, 2H), 2.43 (m, 1H, H-34), 2.36 (t, J = 10.25 Hz, 1H, H-16), 2.04-1.46 (m, 
14H), 1.23 (d, J = 6 Hz, 3H, H-6'), 1.17 (d, J = 6 Hz, 3H, H-38), 1.07-0.89 (m, 87H,), 
0.78-0.56 (m, 54H) 
 
HRMS (ESI) 
calculated for C120H215NO19Si9 (M + Na)+:   2249.3710 
found:        2249.3630 
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Heptakis-triethylsilyl 13-O-Methyl 20, 22, 24, 26, 28, 30, 32-Heptaen-19-one 
Amphoteronolide B Allyl Ester (2.11) 
Compound 2.10 (1.02 g, 0.46 mmol) was dissolved in THF (23 mL) with magnetic stirring under 
argon in the dark.  CaCO3 (467 mg, 4.7 mmol) was added followed by 2,3-dichloro-5,6-dicyano-
1,4-benzoquinone (157 mg, 0.69 mmol) and the reaction stirred at room temperature for 55 
minutes over which time the solution color changed from yellow to orange.  The reaction was 
quenched with saturated aqueous NaHCO3, and diethyl ether was added to the reaction flask.  
Flask contents were transferred to a separatory funnel containing saturated aqueous NaHCO3.  
Diethyl ether was added and the organic phase was washed twice with saturated aqueous 
NaHCO3 and twice with brine.  Aqueous NaHCO3 phases were back-extracted with diethyl ether 
(3 times) until nearly colorless.  The combined organic phases were dried over anhydrous 
Na2SO4, gravity filtered through fluted filter paper, concentrated in vacuo, and purified by flash 
chromatography (SiO2, 10% then 20% ether/petroleum ether) to yield 2.11 as an orange foam 
(430 mg, 0.26 mmol, 57%).   
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TLC (Petroleum ether:diethyl ether 4:1) 
Rf = 0.3 
 
1H NMR (Acetone-d6, 500 MHz), selected resonances   
δ 7.82 (dd, J = 11.25, 15.75 Hz, 1H, H-21), 7.11 (dd, J = 11.5, 14.5 Hz, 1H, H-23), 6,80 
(dd, J = 10.75, 14.75 Hz, 1H, H-25), 6.56 (m, 2H, H-24, H-27), 6.47-6.12 (m, 7H, H-22, 
H-26, H-28 through H-32), 6.03 (d, J = 15.5 Hz, 1H, H-20), 6.00 (m, 1H, Allyl-H), 5.49 
(dd, J = 10.25, 14.75 Hz, 1H, H-33), 5.40 (app ddd, J = 1.5, 3, 15.5 Hz 1H, Allyl-H), 
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5.25 (app ddd, J = 1.5, 2.5, 10.25 Hz, 1H, Allyl-H), 4.66 (app ddd, J = 1.5, 3, 5.5 Hz, 2H, 
Allyl-CH2), 4.46 (m, 2H, H-15, H-37), 4.26 (m, 1H), 4.08 (m, 2H), 3.94 (dd, J = 3, 9.5 
Hz, 1H, H-35), 3.75 (m, 1H, H-17), 3.66 (m, 1H), 3.18 (dd, J = 10.5, 12 Hz 1H, H-18), 
2.90 (s, 3H, C13-OCH3), 2.99 (m, 1H), 2.64 (m, 1H), 2.44 (m, 1H, H-34), 2.38 (t, J = 
10.25 Hz, 1H, H-16), 2.28 (app t, J = 10.75 Hz, 1H), 2.12 (d, J = 12.5 Hz, 1H, H-18), 
1.97-1.70 (m, 9H), 1.67-1.46 (m, 1H), 1.16-1.11 (m, 14H), 1.07-0.94 (m, 52H), 0.90-0.83 
(m, 14H), 0.76-0.52 (m, 34H) 
 
HRMS (ESI) 
calculated for C87H164O14Si7 (M + Na)+: 1652.0404 
found:       1652.0308 
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Heptakis-triethylsilyl-13-O-Methyl Amphoteronolide B Allyl Ester (2.18) 
Compound 2.11 (708 mg, 0.43 mmol) was dissolved in a combination of THF (3.3 mL) and 
methanol (1.1 mL) with magnetic stirring under argon in the dark, and the reaction flask was 
cooled to 0 °C.  NaBH4 (163 mg, 4.3 mmol) was added and the reaction stirred 10 minutes over 
which time the solution color changed from orange to pale yellow. The flask contents were 
transferred to a separatory funnel containing saturated aqueous NH4Cl (~200 mL).  Diethyl ether 
(~200 mL) was added and the organic phase was washed with water (200 mL) and brine (200 
mL), dried over anhydrous Na2SO4, and gravity filtered through fluted filter paper.  The crude 
product was concentrated in vacuo and purified by flash chromatography (SiO2, 10% then 30% 
diethyl ether/petroleum ether) to yield 2.18 as a yellow foam (550 mg, 0.34 mmol, 78%).  
 
 44
OO
O
OSiEt3
CO2Allyl
Me
Me
Me
Et3SiO O O
OSiEt3
O O
Et3Si Et3Si Et3Si Et3Si
OMe
OH
2.18  
 
TLC (Petroleum ether:diethyl ether 7:3) 
Rf = 0.34 
 
1H NMR (Acetone-d6, 500 MHz) 
δ 6.50-6.11 (m, 13H, H-20 through H-32), 5.98 (app ddd, J = 6, 11, 16.5 Hz, 1H, Allyl-
H), 5.52 (dd, J = 9.5, 15 Hz, 1H, H-33), 5.38 (ddd, J = 1.5, 3, 17 Hz, 1H, Allyl-H), 5.23 
(app dd, J = 1.5, 10 Hz, 1H, Allyl-H), 4.70 (m, 1H, H-37), 4.61 (m, 2H, Allyl-CH2), 4.50 
(m, 1H, H-19), 4.43 (dt, J = 5, 11 Hz, 1H, H-15), 4.24 (m, 1H), 4.12 (app t, J = 10 Hz, 
1H), 4.05 (m, 1H, H-17), 3.99 (sep, 4.25 Hz, 1H), 3.93 (d, J = 4 Hz, 1H, C19-OH), 3.83 
(dd, J = 3, 9 Hz, 1H, H-35), 3.69 (m, 1H), 3.62 (app dd, J = 4.5, 10.5 Hz, 1H), 3.15 (s, 
3H, C13-OCH3), 2.81 (s, 1H), 2.56 (m, 2H), 2.42 (m, 1H, H-34), 2.33 (t, J = 10 Hz, 1H, 
H-16), 2.10 (dd, J = 4.5, 12.5 Hz, 1H, H-14), 1.99 (m, 1H), 1.94-1.57 (m, 14H), 1.51 (m, 
1H), 1.17 (d, J = 6 Hz, 3H, H-38), 1.06-0.93 (m, 69H), 0.76-0.57 (m, 42H). 
 
HRMS (ESI) 
calculated for C87H166O14Si7 (M + Na)+: 1654.0560 
found:       1654.0493 
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13-O-Methyl Amphoteronolide B Allyl Ester (2.12) 
Compound 2.18 (550 mg, 0.34 mmol) was dissolved in THF (5 mL) in a plastic bottle with 
magnetic stirring under argon in the dark, and the reaction bottle was cooled to 0 °C.  A separate 
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plastic bottle was charged with THF (3.8 mL) and 70% HF/Pyridine (6.4 mL) and cooled to 0 
°C.  Pyridine (6.4 mL) was added dropwise to the second bottle over 5 minutes, and the 
HF/Pyridine solution was cannulated to the plastic bottle containing 2.18. The reaction was 
stirred for 12 hours at which time the reaction was quenched with saturated aqueous NaHCO3 
and transferred to a separatory funnel containing saturated aqueous NaHCO3 (~200 mL).  20% 
methanol/methylene chloride was added and the aqueous phase was washed with 20% 
methanol/methylene chloride until colorless.  The combined organic washes were concentrated 
in vacuo to remove approximately one-half of the solvent and benzene (~150 mL) was added to 
the flask.  Flask contents were concentrated in vacuo and the crude product was purified by flash 
chromatography (SiO2, 10% methanol/methylene chloride) to yield 2.12 as a yellow-orange solid 
(239 mg, 0.29 mmol, 84%).  HRMS (ESI) calculated for C45H68O14 (M + Na)+: 855.46, found: 
855.4. 
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TLC (CH2Cl2:MeOH 4:1) 
Rf = 0.64 
 
1H NMR (CD3OD, 400 MHz) 
δ 6.46-6.10 (m, 12H), 5.98 (app ddd, J = 5.6, 11.2, 16.4 Hz, 1H), 5.80 (dd, J = 7.6, 14.8 
Hz, 1H), 5.47 (dd, J = 9.6, 14 Hz, 1H), 5.38 (ddd, J = 1.6, 32., 17.2 Hz, 1H), 5.24 (app 
dd, J = 1.6, 10.4 Hz, 2H), 4.66 (app d, J = 5.6 Hz, 2H), 4.47 (dd, J = 7.2, 12 Hz, 1H),  
4.25-4.14 (m, 5H), 3.99 (m, 1H), 3.90 (app d, J = 4.4 Hz, 1H), 3.70 (m, 1H), 3.53 (app d, 
J = 10.8 Hz, 1H), 3.27-3.20 (m, 2H), 3.18 (s, 3H), 2.43-2.16 (m, 5H), 2.11 (dd, J = 4.8, 
13.2 Hz, 1H), 1.89-1.25 (m, 10H), 1.19 (d, J = 6.4 Hz, 3H), 1.11 (d, J = 6.4 Hz, 3H), 1.00 
(d, J = 7.4 Hz, 3H). 
 
HRMS (ESI) 
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calculated for C45H68O14 (M + Na)+:  855.4507 
found:       855.4531 
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Amphoteronolide B Allyl Ester (2.14) 
Compound 2.12 (68.4 mg, 0.082 mmol) was dissolved in a combination of THF ( mL) and water 
( mL) with magnetic stirring under argon in the dark.  (±)-10-camphorsulfonic acid (5.7 mg, 
0.025 mmol) was added and the reaction was stirred for 5.5 hours at room temperature.  The 
reaction was quenched with triethylamine and flask contents were concentrated in vacuo to 
remove THF and precipitate the crude product as an aqueous slurry.  The yellow precipitate was 
collected by vacuum filtration.  The filter cake was washed with water, the solid collected, and 
the filter paper washed with THF and acetonitrile.  The crude solid was concentrated in vacuo to 
yield 2.14 as a yellow solid (51.4 mg, 0.063 mmol, 77%).  The characterization below is of the 
actual material used in NMR studies (synthesized by Dan Palacios, NMR characterization by the 
author). 
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 Proton and coupling constant assignments were made using 
a variety of two-dimensional NMR techniques including 
phase-sensitive COSY experiments combined with 
amplitude constrained multiplet evaluation (ACME).6b The 
polyene macrolide skeletons of 2.1 - 2.4 are quite rigid and 
hydrogen atoms can be assigned as having 
pseudoequatorial (e) and pseudoaxial (a) orientations.2 The labeling scheme used herein is 
consistent with that utilized by Sowinski et al.1 
 
HPLC 
tR = 28.6 min; flow rate = 25 mL/min, gradient of 5 → 95% MeCN in H2O over 25 min. 
 
1H NMR (500 MHz, pyridine d-5:CD3OD 10:1) 
δ 6.83 (dd, J = 11, 15 Hz, 1H, H-22), 6.77 (dd, J = 11, 15 Hz, 1H, H-24), 6.69 (dd, J19.20 
= 9.5 Hz, J20,21 = 15.5 Hz, 1H, H-20), 6.61 (dd, J = 14.5, 15 Hz, 1H, H-26), 6.54-6.35 (m, 
9H), 6.04-5.96 (app ddd, J42,43 = 6.5, J43,44cis = 11 Hz, J43,44trans = 17 Hz, 1H, H-43), 5.80 
(app d, J36,37 = 1.9 Hz, 1H, H-37), 5.55 (dd, J32,33 = 15 Hz, J33,34 = 10.1 Hz, 1H, H-33), 
5.42 (dd, J44cis,44trans = 1.5 Hz, J43,44trans = 17.5 Hz, 1H, H-44trans), 5.30 (app t, J16,17 = 
10.6 Hz, J17,18e = 0.9 Hz, J17,18a = 8.7 Hz, 1H, H-17), 5.14 (dd, J44cis,44trans = 1.5 Hz, J43,44cis 
= 10.5 Hz, 1H, H-44cis), 5.06 (app dt, J14e,15 = 3.5 Hz, J14a,15 = 11.0 Hz, J15,16 = 10.7 Hz, 
1H, H-15), 4.87 (t, J10a,11 = 3.1 Hz, J10e,11 = 10.3 Hz, J11,12a = 3.4 Hz, J11,12e = 11.3 Hz, 1H, 
H-11), 4.80-4.73 (m, J18e,19 = 6.0 Hz, J19,20 = 8.8 Hz, 3H, H-19, H-42(2)), 4.64 (app t, J2a,3 
= 4.7 Hz, J2e,3 = 9.2 Hz, J3,4a = 3.9 Hz, J3,4e = 10.1 Hz, 1H, H-3), 4.13 (app t, J4a,5 = 4.4 
Hz, J4e,5 = 9.5 Hz, J5,6a = 5.4 Hz, J5,6e = 10.3 Hz, 1H, H-5), 4.04 (app d, J8,9 = 3.0 Hz, J9,10a 
= 3.3 Hz, J9,10e = 10.7 Hz, 1H, H-9), 3.61 (app d, J7e,8 = 2.8 Hz, J7a,8 = 11.2 Hz, J8,9 = 3.0 
Hz, 1H, H-8), 3.43 (app d, J34,35 = 9.8 Hz, J35,36 = 2.6 Hz, 1H, H-35), 2.85 (t, J15,16 = 10.7 
Hz, J16,17 = 10.6 Hz, 1H, H-16), 2.66 (m, J33,34 = 10.1 Hz, J34,35 = 9.8 Hz, 1H, H-34), 2.61 
(dd, J2a,2e = 17 Hz J2e,3 = 9.2 Hz, 1H, H-2e), 2.51 (dd, J14a,14e = 12 Hz J14e,15 = 3.5 Hz, 1H, 
H-14e), 2.46 (dd, J2a,2e = 16.5, J2a,3 = 4.7, 1H, H-2a), 2.41 (dd, J17,18e = 0.9 Hz, J18a,18e = 
14 Hz, J18e,19 = 6.0 Hz, 1H, H-18e), 2.37 (m, J7e,8 = 2.8 Hz, 1H, H-7e), 2.19-2.15 (m, J9,10e 
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= 10.7 Hz, J10e,11 = 10.3 Hz, J17,18a = 8.7 Hz. 2H, H-10e, H18a), 2.10 (m, J35,36 = 2.6 Hz, 
J36,37 = 1.9 Hz, 1H, H-36), 2.00-1.95 (m, J5,6e = 10.3 Hz, J11,12e = 11.3 Hz, 2H, H-6e, H-
12e), 1.85-1.80 (m, J3,4e = 10.1 Hz, J4e,5 = 9.5 Hz, J7a,8 = 11.2 Hz, J14e,15 = 3.5 Hz,  3H, H-
4e, H-7a, H-14e), 1.78-1.70 (m, J5,6a = 5.4 Hz, J11,12a = 3.4 Hz, 2H, H-6a, H-12a), 1.61 
(app t, J3,4a = 3.9 Hz, J4a,5 = 4.4 Hz, 1H, H-4a), 1.56 (app d, J9,10a = 3.3 Hz, J10a,10e = 14.5 
Hz, J10a,11 = 3.1 Hz, 1H, H-10a), 1.46 (d, J37,38 = 6.5 Hz, 3H, H-38), 1.31 (d, J34,40 = 6 Hz, 
3H, H-40), 1.25 (d, J36,39 = 7 Hz, 3H, H-39). 
 
13C NMR (150 MHz, pyridine d-5:CD3OD, 10:1) 
δ 173.5, 172.2, 140.9, 137.5, 135.0, 134.8, 134.7, 134.1, 133.7, 133.5, 133.4, 133.3, 
133.2, 133.1, 132.9, 132.8, 129.1, 118.0, 98.6, 78.8, 76.3, 75.2, 72.2, 71.1, 70.4, 69.7, 
68.5, 68.1, 67.0, 66.7, 65.4, 59.0, 47.6, 45.9, 45.1, 43.8, 43.0, 42.8, 41.1, 41.0, 39.4, 36.6, 
31.8, 30.2, 29.5, 26.0, 24.4, 23.5, 19.1, 17.4, 12.9. 
 
HRMS (ESI) 
 calculated for C44H66O14 (M+Na)+: 841.4350 
found:      841.4369 
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Amphoteronolide B (2.3) 
Compound 2.14 was dissolved in THF (3.9 mL) with magnetic stirring under argon in the dark.  
Pyrrolidine (16 μL) followed by Pd(PPh3)4 (0.5 mL of a 0.017 M solution in THF, 0.008 mmol) 
were added sequentially. The crude product precipitated immediately and the reaction was stirred 
for 30 minutes. Flask contents were diluted with ether and the precipitate was collected by 
vacuum filtration, washing the filter cake with ether.  The yellow solid was collected and 
acetonitrile added to coevaoporate residual THF/ether/pyrrolidine.  The crude product was 
dissolved in 1:1 THF/methanol, filtered through a 0.2 micron syringe filter and purified by 
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HPLC (10 x 250 SunFire C18 ODS column) to yield 2.3 as a pale yellow solid ( 40 mg, 16 %). 
In the initial synthesis of 2.3, a clean NMR spectrum was not obtained due to decomposition. 
Full characterization of 2.3 was accomplished by Dan Palacios. As 2.3 was also used in yeast 
assays, full characterization is shown below. 
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HPLC 
tR: 21.6 min; flow rate = 25 mL/min, gradient of 0 → 75% MeCN in 10 mM ammonium 
acetate over 25 min. 
 
 
 
1H NMR (pyridine d-5:CD3OD 10:1) 
δ 6.76-6.67 (m, 2H), 6.59-6.55 (m, 2H), 6.45-6.35 (m, 10H), 5.72 (app d, J = 5 Hz, 1H), 
5.16 (app t, J = 10 Hz, 1H), 4.92 (bs, 1H), 4.78 (bs, 2H), 4.57 (app t, J = 10 Hz, 1H), 4.05 
(app t, 9.5 Hz, 1H), 3.95 (app d, J = 10.5 Hz, 1H), 3.65 (app d, J = 4 Hz, 1H), 3.52 (app 
d, J = 10.5 Hz, 1H), 3.41 (app d, J = 9 Hz, 1H), 2.64 (bs, 2H), 2.56 (dd, J = 10, 16.5 Hz, 
1H), 2.43-2.40 (m, 2H), 2.24 (bs, 2H), 2.10-2.05 (m, 2H), 1.95-1.90 (m, 2H), 1.79-1.65 
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(m, 5H), 1.58 (app d, J = 13.5 Hz, 1H), 1.51 (app d, J = 11 Hz, 1H), 1.41 (d, J = 6.5 Hz, 
3H), 1.28 (d, J = 6.5 Hz, 3H), 1.21 (d, J = 7 Hz, 3H). 
 
HRMS 
 Calculated for C41H62O14 (M+Na)+: 801.4037 
found:      801.4039 
 
 
 
OH
O
OH
Me
OHOMe
OHOH
OH
OHOHO
Me
HO
Me
2.2
1 3 5 7 9 11
13 15
17
41
19
21232527293133
35
37
38
39
40
 
 
 
 
C41-Methyl amphoteronolide B (2.2) 
Compound 2.2 was synthesized and purified by Dan Palacios for use in NMR and yeast studies 
as was recently described.5 Full NMR characterization was completed by the author.  
 
HPLC 
tR = 24.9 min, flow rate = 25 mL/min, gradient of 5 → 95% MeCN in H2O over 25 min. 
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1H NMR (600 MHz, pyridine d-5, CD3OD 10:1) 
 δ 6.83 (dd, J  = 10.8, 14.7 Hz, 1H, H-22), 6.77 (dd, J  = 10.8, 15 Hz, 1H, H-24), 6.70 (dd, 
J19,20 = 8.9 Hz, J20,21 = 15 Hz, 1H, H-20), 6.60 (dd, J = 11.4, 14.4 Hz, 1H, H-23), 6.55-
6.35 (m, 9H), 5.79 (app d, J36,37 = 3.1 Hz, 1H, H-37), 5.55 (dd, J32,33 = 15.6, J33,34  = 9.9 
Hz, 1H, H-33), 4.87 (app t, J10a,11  = 1.3 Hz, J10e,11 = 10.9 Hz, J11,12a = 1.2 Hz, J11,12e = 10.7 
Hz, 1H, H-11), 4.77 (m, J18a,19 = 3.9, J18e,19 = 5.5 Hz, J19,20 = 8.9 Hz, 1H, H-19), 4.65 (m, 
J2e,3 = 9.2 Hz, J3,4a = 4.3, J3,4e = 10.9 Hz, J16,17 = 10.8 Hz, J17,18a = 8.1 Hz, 2H, H-3, H-17), 
4.20 (app dt, J14e,15 = 2.1, J14a,15 = 11.5 Hz, J15,16 = 10.8 Hz, 1H, H-15), 4.12 (app t, J4a,5 = 
1.8, J4e,5 = 10.3 Hz, J5,6a = 1.1, J5,6e = 11.5 Hz, 1H, H-5), 4.03 (app dd, J8,9 = 3.2 Hz, J9,10a  
= 2.3, J9,10e = 11.7 Hz, 1H, H-9), 3.60 (app dd, J7e,8 = 2.4, J7a,8 = 11.3 Hz, J8,9 = 3.2 Hz, 
1H, H-8), 3.44 (app d, J34,35 = 10.0 Hz, J35,36 = 2.6 Hz, 1H, H-35), 2.68 (m, J33,34 = 9.9 Hz, 
J34,35 = 10.0 Hz, 1H, H-34), 2.62 (dd, J2a,2e  = 16.2 Hz, J2e,3 = 9.2 Hz, 1H, H-2e), 2.49-2.44 
(m, J14e,15 = 2.1 Hz, J18e,19 = 5.5 Hz, 3H, H-2a, H-14e, H-18e), 2.37-2.34 (m,  J6a,7a = 10.6 
Hz, J6e,7a = 5.7 Hz, J7a,8 = 11.3, 1H, H-7a), 2.19-2.15 (m, J9,10e = 11.7 Hz, J10e,11 = 10.9 Hz, 
1H, H-10e) 2.13-2.10 (m, J35,36 = 2.6 Hz, J36,37 = 3.1 Hz, 1H, H-36), 2.02 (ddd, J17,18a = 8.1 
Hz, J18a,18e = 14.4 Hz, J18a,19 = 3.9 Hz, 1H, H-18a), 1.99-1.95 (m, J5,6e = 11.5 Hz, J6e,7a = 
5.7 Hz, J6e,7e = 13.5 Hz, J11,12e = 10.7 Hz, 2H, H-6e, H-12e), 1.85-1.74 (m, J3,4e = 10.9 Hz, 
J4e,5 = 10.3 Hz, J6e,7e = 13.5 Hz, J7e,8 = 2.4 Hz, J11,12a = 1.2 Hz, J14a,15 = 11.5 Hz, 4H, H-4e, 
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H-7e, H-12a, H-14a), 1.72-1.66 (m, J5,6a = 1.1 Hz, J6a,7a = 10.6 Hz, J15,16 = 10.8 Hz, 2H, 
H-6a, H-16), 1.63 (app dt, J3,4a = 4.3 Hz, J4a,4e = 14.1 Hz, J4a,5 = 1.8 Hz, 1H, H-4a), 1.56 
(app dd, J9,10a = 2.3Hz, J10a,10e = 14.4 Hz, J10a,11 = 1.3 Hz, 1H, H-10a), 1.45 (d, J37,38 = 6.6 
Hz, 3H, H-38), 1.34 (d, J16,41 = 6 Hz, 3H, H-41), 1.31 (d, J34,40 = 6 Hz, 3H, H-40), 1.24 (d, 
J36,39 = 7.2 Hz, 3H, H-39). 
 
13C NMR (150 MHz, pyridine d-5 : CD3OD, 10:1) 
δ 172.1, 141.4, 137.5, 135.1, 134.8, 134.2, 133.6, 133.4, 133.1, 132.8, 132.7, 129.1, 98.3, 
78.7, 76.3, 75.3, 75.2, 72.2, 71.4, 70.4, 69.7, 68.5, 48.2, 46.7, 45.1, 44.4, 43.8, 43.0, 41.5, 
41.2, 41.0, 36.6, 31.9, 30.2, 29.8, 19.1, 17.4, 14.1, 12.8. 
 
HRMS (ESI) 
 calculated for C41H64O12 (M + Na)+: 771.4295 
found:     771.4268 
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C41-Methyl amphotericin B (2.4) 
Compound 2.4 was synthesized, purified, and characterized by Dan Palacios for use in yeast 
studies as was recently described.5 
 
HPLC 
tR = 21.7 minutes; flow rate = 25 mL/min, gradient of 5 → 95% MeCN in 5 mM 
ammonium acetate over 25 min. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1H NMR (500 MHz, pyridine d-5:CD2OD 10:1) 
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δ 6.78-6.71 (m, 2H), 6.58-6.37 (m, 9H), 6.43-6.35 (m, 2H), 5.77 (app d, J = 5.5 Hz, 1H), 
5.54 (dd, J = 10, 15 Hz, 1H), 4.95 (s, 1H), 4.81-4.77 (m, 2H), 4.61 (dt, J = 3, 12.5 Hz, 
1H), 4.45-4.40 (m, 2H), 4.35 (d, J = 2.5 Hz, 1H), 4.11-4.03 (m, 2H), 4.00 (app d, J = 11 
Hz, 1H), 3.77 (t, J = 9 Hz, 1H), 3.66-3.58 (m, 2H), 3.57 (app d, J = 11 Hz, 1H) 3.42 (app 
d, J = 9.5 Hz, 1H), 2.66 (app dd, J = 7, 9.5 Hz, 1H), 2.60 (dd, J = 9.5, 16.5 Hz, 1H), 2.49 
(dd, J = 5.5, 14.5 Hz, 1H), 2.41 (app dd, J = 7.5, 12 Hz, 2H), 2.39-2.35 (m, 1H), 2.10 
(app dd, J = 7.5, 15.5, 2H), 1.95-1.88 (m, 3H), 1.81-1.72 (m, 3H), 1.70-1.67 (m, 2H), 
1.66-1.59 (m, 2H), 1.52 (d, J = 6 Hz, 3H), 1.44 (d, J = 6.5 Hz, 3H), 1.30 (d, J = 6.5 Hz, 
3H), 1.24 (d, J = 7 Hz, 3H), 1.22 (d, J = 6.5 Hz, 3H). 
 
HRMS (ESI) 
 calculated for C47H75NO15 (M + Na)+: 894.5191 
found:      894.5182 
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N-acyl amphotericin B methyl ester (2.13) 
Compound 2.13 was prepared as described by Nicolaou et al.3a 
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N-Fmoc-41-methyl amphotericin B (2.15)  
Compound 2.15 was synthesized and purified by Dan Palacios for use in NMR studies as was 
recently described.5 Full NMR characterization was completed by the author. 
 
HPLC 
tR = 25.1 minutes; flow rate = 25 mL/min, gradient of 5 → 95% MeCN in 5 mM 
ammonium acetate over 25 min. 
 
1H NMR (600 MHz, pyridine d-5:CD3OD 10:1) 
δ 7.85 (d, J = 7.2 Hz, 2H), 7.71 (dd, J = 6, 8.5 Hz, 2H), 7.41 (t, J = 7.2 Hz, 2H), 6.74 (m, 
2H), 6.60-6.34 (m, 11H), 5.77 (app d, J36,37 = 1.8 Hz, 1H, H-37), 5.54 (dd, J32,33 = 15 Hz 
J33,34 = 10.0, 1H, H-33), 4.97 (app s, J1’,2’ = 1.6 Hz, 1H, H-1’), 4.82-4.78 (m, J10e,11 = 10.4 
Hz, J11,12e = 11.0 Hz, J18a,19 = 2.5 Hz, J18e,19 = 4.6 Hz, J19,20 = 8.0 Hz, 2H, H-11, H-19), 
4.62 (app t, J2a,3 = 1.8 Hz, J2e,3 = 9.1 Hz, J3,4a = 2.0 Hz, J3,4e = 10.1 Hz, 1H, H-3), 4.51-
4.43 (m, J16,17 = 10.4 Hz, J17,18a = 7.5 Hz, 3H, H-17, H-1’’(2)), 4.39 (app d, J1’,2’ = 1.6 Hz, 
1H, H-2’), 4.34 (dd, J2’,3’ = 3 Hz, J3’,4’  = 9.7 Hz, 1H, H-3’), 4.29 (t, J = 7.2 Hz, 1H, H-
2’’), 4.12-4.07 (m, J4a,5 = 1.0 Hz, J4e,5 = 9.6 Hz, J5,6a = 1.8 Hz, J5,6e = 10.7 Hz, J14e,15 = 2.6 
Hz, J14a,15 = 11.8 Hz, J15,16 = 11.2 Hz, 2H, H-5, H-15), 4.02-3.99 (m, J8,9 = 3.4 Hz, J9,10a = 
2.6 Hz, J9,10e = 10.7 Hz, J3’,4’ = 9.7 Hz, J4’,5’ = 9.1 Hz, 2H, H-9, H-4’), 3.73 (app dd, J4’,5’ 
= 9.1 Hz, J5’,6’  = 6.6 Hz, 1H, H-5’), 3.58 (app d, J7e,8 = 2.5 Hz, J7a,8 = 10.6 Hz, J8,9 = 3.4 
Hz, 1H, H-8), 3.43 (app d, J34,35 = 9.6 Hz, J35,36 = 2.5 Hz, 1H, H-35), 2.67 (app dd, J33,34 = 
10.0 Hz, J34,35 = 9.6 Hz, 1H, H-34), 2.60 (dd, J2a,2e = 16.8 Hz, J2e,3 = 9.1 Hz, 1H, H-2e), 
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2.46 (app dd, J18a,18e = 16.8 Hz, J18e,19 = 4.6 Hz, 1H, H-18e), 2.44-2.40 (m, J2a,3 = 1.8 Hz, 
J14e,15 = 2.6 Hz, 2H, H-2a, H-14e), 2.36-2.33 (m, J6e,7e = 13.4 Hz, J7e,8 = 2.5 Hz, 1H, H-
7e), 2.17-2.07 (m, J9,10e = 10.7 Hz, J10e,11 = 10.4 Hz, J35,36 = 2.5 Hz, J36,37 = 1.8 Hz, 2H, 
H-10e, H-36), 2.02-1.90 (m, J5,6e = 10.7 Hz, J6e,7a = 4.4 Hz, J6e,7e = 13.4 Hz, J11,12e = 11.0 
Hz, J17,18a = 7.5 Hz, J18a,19 = 2.5 Hz, 3H, H-6e, H-12e, H-18a), 1.81-1.76 (m, J3,4e = 10.1 
Hz, J4e,5 = 9.6 Hz, J6e,7a = 4.4 Hz, J6a,7a = 12.7 Hz, J7a,8 = 10.6 Hz, 3H, H-4e, H-7a, H12a), 
1.73-1.69 (m, J5,6a = 1.8 Hz, J6a,7a = 12.7 Hz, J14a,15 = 11.8 Hz, 2H, H-6a, H-14a), 1.62-
1.60 (m, J3,4a = 2.0 Hz, J4a,5 = 1.0 Hz, J15,16 = 11.2 Hz, J16,17 = 10.4 Hz, 2H, H-4a, H-16), 
1.56 (d, J5’,6’ = 6.6 Hz, 3H, H-6’), 1.55-1.52 (m, J9,10a = 2.6 Hz, 1H, H-10a), 1.44 (d, J37,38 
= 6.6 Hz, 3H, H-38), 1.30 (d, J34,40 = 6.6 Hz, 3H, H-40), 1.24 (d, J36,39 = 7 Hz, 3H, H-39), 
1.23 (d, J16,41 = 5.2 Hz, 3H, H-41). One of the Fmoc proton resonances was obscured by 
a solvent peak. 
  
13C NMR (150 MHz, pyridine d-5:CD3OD 10:1) 
δ 172.2, 158.0, 145.1, 144.9, 142.0, 141.9, 138.2, 137.6, 134.9, 134.8, 134.5, 134.1, 
133.7, 133.5, 133.4, 133.2, 132.9, 130.3, 128.3, 127.8, 126.1, 123.6, 126.0, 120.7, 108.6, 
99.6, 98.3, 78.8, 78.1, 76.3, 75.3, 75.0, 72.2, 71.9, 71.5, 70.4, 69.7, 69.5, 68.5, 67.6, 67.1, 
58.7, 48.1, 45.1, 44.2, 43.1, 41.1, 36.6, 30.3, 19.1, 18.8, 17.5, 14.1, 12.8. 
 
HRMS (ESI)  
calculated for C62H85NO17 (M + Na)+: 1138.5715 
found:      1138.5734 
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Part 2: 2-D NMR Acquisition and  Data Processing 
gCOSY NMR spectra. 500 MHz and 600 MHz gCOSY NMR spectra were acquired at 30 °C 
with 2048 points, 256 or 512 increments and 1, 4, or 8 transients. Spectra were processed on a 
SUN Microsystems SPARCstation Ultra 5 computer using Varian VNMR software, version 6.1, 
revision C, with zero-filling to 4096 x 4096 and sine bell apodization such that sb = at/2 and sb1 
= ni/(2*sw1).  
H-H NOESY NMR spectra. Samples for NOESY NMR experiments were prepared in an 
Innovative Technologies, Inc. glove box using a NMR tube sealed with a PTFE screw cap. 
Sealed ampoules of pyridine d-5 and CD3OD with 0.03% tetramethylsilane were used as solvents 
for these experiments. 600 MHz NOESY spectra were acquired at 30 °C with 2048 points, 256 
increments, 8 transients per increment, τmix = 0.7 s, and an interscan delay (d1) of 3*T1 (standard 
T1 relaxation experiments were performed for each compound). Spectra were processed using 
nmrPipe as follows: 1) 4 points back prediction, 2) 90° shifted sinebell apodization, 3) zero-
filling to 8192 points, 4) Fourier transformation and phasing, 5) linear prediction to 512 points, 
6) 90° shifted sinebell apodization, 7) zero-filling to 2048 points, and 8) Fourier transformation 
and phasing. The Sparky program,18 version 3.113 was used for peak-picking and integration of 
crosspeaks. Distance restraints were derived and enforced in conformational searches as 
described in the text.  
Phase-sensitive COSY (COSYPS) NMR spectra. 500 MHz COSYPS spectra were acquired at 
30 °C with 2048 points, 256 increments, and 4 transients per increment. 600 MHz COSYPS 
spectra were acquired at 30 °C with 2458 points, 308 increments and 8 transients per increment. 
All COSYPS spectra were acquired with sufficient interscan delay to allow for full spin-
relaxation (d1 = 23.2 seconds, as determined by T1 relaxation experiments, was sufficient for all 
compounds). Coupling constants and associated dihedral angles were determined as described in 
the text. 
Gradient HMBC NMR spectrum. A gradient HMBC spectrum of N-acyl AmB methyl ester 
2.13 was acquired at 23 °C with 2048 points, 280 increments, and 128 transients. Parameters for 
C-H coupling were set such that j1xh = 140 Hz and jnxh = 8 Hz.  The spectrum was processed 
on a SUN Microsystems SPARCstation Ultra 5 computer using Varian VNMR software, version 
6.1 revision C, with zero-filling to 1024 points in the indirect dimension and sinebell apodization 
such that sb = at/2 and sb1 = ni/(2*sw1). 
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Part 3. Conformational searches and RMS atom alignment 
NMR-Restrained Model Structures.  Monte Carlo conformational searches were performed 
using the Molecular Operating Environment program (MOE), Version 2006.08,19 with the 
empirical MMFF94x force field and a Born solvation model with no distance cutoffs for non-
bonded interactions. Initial atomic coordinates and structure files were generated from the AmB 
crystal structure using MOE. NMR-derived distance and dihedral constraints were set with a 
weighting factor of 200. 3500 random conformations were generated and minimized with 
Gaussian distribution of dihedrals biased towards multiples of 30°, dihedral minimization (RMS 
= 100), 0.001 Cartesian minimization RMS gradient, 0.0001 Cartesian perturbation, 0.1 RMS 
tolerance, a maximum of 2000 energy minimization steps for each minimization, a failure limit 
of 5000, no chiral inversion, no rotation about π bonds or amide bonds, and an energy cutoff of 5 
kcal/mol. Force field partial charges were calculated before each minimization. Default values 
were used for all other parameters. 
Rigid RMS atom alignment for NMR-restrained model structures. The macrolactone and 
hemiketal atoms from each lowest energy conformation were saved as MDL MOL files (*.mol) 
and imported into the Cerius2 program, Version 4.11,20 with no energy minimization or 
calculation of charges. After rigid RMS atom alignment, the aligned structures were saved as 
PDB files (*.pdb), and the overlay image (Figure 2-9) was generated using Visual Molecular 
Dynamics (VMD).21 
Part 4. Antifungal Assays 
Growth conditions for Saccharomyces cerevisiae. S. cerevisiae (ATCC 9763) cultures were 
incubated at 30 ºC on yeast peptone dextrose (YPD) agar plates or in YPD liquid cultures with 
rotary shaking. For liquid YPD medium, yeast extract (5 g), Bacto peptone (10 g), and MilliQ 
H2O (475 mL) were combined and autoclaved at 250 ºC for 15 minutes. Sterile 40% w/v aqueous 
glucose (25 mL) was subsequently added (sterile glucose solutions were prepared by dissolving 
glucose in MilliQ water and autoclaving at 250 ºC for 12 min). For agar plates, the same 
procedure was used except using only 225 mL of water and combining with 250 mL sterile 4% 
w/v aqueous agar solution (sterile 4% w/v agar was prepared by adding agar to MilliQ water and 
autoclaving at 250 ºC for 15 min). Agar plates were prepared by pouring the hot YPD/agar 
mixture into sterile 15 mm x 100 mm culture dishes. The plates were allowed to cool at room 
temperature until the agar had solidified.  
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Growth conditions for Candida albicans. C.albicans (ATCC 90028) were cultured in the same 
manner as S. cerevisiae except the cells were incubated at 37 °C rather than 30 °C. 
Disk Diffusion Assay. Protocols for disk diffusion assays were adapted from the National 
Committee of Clinical Laboratory Standards document M2-A8.22 Yeast were streaked on YPD 
agar plates with a sterile toothpick and incubated at 30 ºC (S. cerevisiae) or 37 °C (C. albicans) 
until individual colonies could be identified by eye (~ 24 h). Five individual colonies were 
transferred from the agar plate with an inoculating loop to the liquid YPD medium. The liquid 
culture was incubated overnight at 30 °C (S. cerevisiae) or 37 °C (C. albicans) in a shaker 
incubator (200 rpm). The saturated cell culture was diluted with YPD medium to an OD600 of 0.1 
(~ 3 x 107 cells/mL) as measured on a Shimadzu PharmaSpec UV-1700 UV/Visible 
spectrophotometer. This culture was used to inoculate an YPD plate by streaking the entire plate 
with a sterile cotton tip applicator three times, turning the plate approximately 60 ° after each 
application and finishing by swabbing the rim of the agar. The plate was allowed to dry for 
approximately 2 to 3 minutes before application of paper disks impregnated with compounds 
2.1-2.4. The disks were prepared in the following manner: 10 microliters of a 4 mg/ml (S. 
cerevisiae) or a 2 mg/mL (C. albicans) solution of each compound in DMSO was added to an 8 
mm disk of Whatman 4 filter paper. Controls were prepared in a similar manner using only 
DMSO. The disks were then placed on the agar and gently pressed with forceps. All disks, 
including DMSO controls, were added within 15 minutes of inoculation. After disks were added 
to the plate the plate was inverted and incubated at 30 °C (S. cerevisiae) or 37 °C (C. albicans) 
for 36 to 48 hours prior to assessment. Those compounds which showed a visible zone of growth 
inhibition were judged to be active. This experiment was repeated for each yeast strain and 
yielded the same results. See Figure 2-10 
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Figure 2-10. Representative results of disk diffusion assays for S. cerevisiae (left) 
and C. albicans. Adapted with permission from Palacios, D.S.; Anderson, T.M.; 
Burke, M.D. J. Am. Chem. Soc.  2007, 129, 13804-13805. Copyright 2007 American 
Chemical Society. 
 
Broth microdilution minimum inhibitory concentration (MIC) assays. Protocols for broth 
microdilution assays were adapted from the National Committee of Clinical Laboratory 
Standards document M27-A223 and from the protocol reported by Paquet and Carreira.24 Yeast 
were streaked on YPD agar plates with a sterile toothpick and incubated at 30 °C (S. cerevisiae) 
or 37 °C (C. albicans) until individual colonies could be identified by eye (~ 24 h). Five 
individual colonies were transferred from the agar plate with an inoculating loop to the liquid 
YPD medium. The liquid culture was incubated overnight at 30 °C (S. cerevisiae) or 37 °C (C. 
albicans) in a shaker incubator (200 rpm). The saturated cell culture was diluted with YPD 
medium to an OD600 of 0.1 (~ 3 x 107 cells/mL) as measured on a Shimadzu PharmaSpec UV-
1700 UV/Visible spectrophotometer. Aliquots (195 μL) of the resulting cell suspension were 
added to a 96-well plate. Compounds for testing were prepared as 400 μM solution in DMSO 
and this stock solution was serially diluted to concentrations of 320, 240, 200, 160, 120, 80, 40, 
20, 10, and 5 μM. Aliquots (5 μL) of each DMSO solution were added to the 96-well plate, with 
each row of the plate containing a different concentration. This 40-fold dilution resulted in final 
compound concentrations of 10, 8, 6, 5, 4, 3, 2, 1, 0.5, 0.25, and 0.125 μM. DMSO (5 μL) was 
added as a control to each well of the final row. Each concentration was tested in triplicate. 
Plates were covered with Corning Thermowell aluminum sealing tape and incubated at 30 °C (S. 
cerevisiae) or 37 °C (C. albicans) for 18 hours. MIC values were determined as concentration 
corresponding to the row which showed no visible growth. The assay was repeated three times 
and the reported values represent the average of these three experiments.       
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CHAPTER 3 
Discovery of a lipid platform for SSNMR analysis of AmB in phospholipid bilayers 
 
ABSTRACT  
Having discovered that the channel and antifungal activity of MeAmB is not consistent 
with the leading model for the antifungal action of AmB, we sought to complement these 
experiments with structural characterization of AmB in phospholipid bilayers. SSNMR has 
recently emerged as a powerful tool for studying membrane-bound molecules, particularly 
membrane proteins. However, application of SSNMR to the study of membrane-bound small 
molecules has been limited. To enable relevant SSNMR studies of AmB in the presence of lipid 
bilayers, we recognized a need to achieve three goals: 1) gain access to highly 13C-enriched AmB, 
2) develop a physiologically relevant phospholipid bilayer system compatible with high 
resolution SSNMR studies with AmB, and 3) complete de novo assignments of the 13C spectrum 
of AmB.  This chapter describes the development of solutions to each of these problems. First, 
by growing the AmB producing organism, Streptomyces nodosus, in the presence of growth 
medium containing only uniformly 13C-labeled glucose as a carbon source, we have developed a 
reproducible process for the biosynthesis of >80% uniformly 13C-labeled AmB (the highest 
percent incorporation reported to date).. Second, as part of our efforts to develop a 
physiologically relevant lipid bilayer platform suitable for SSNMR studies of AmB, we 
extensively investigated the use of nanoscale discoidal lipid bilayers (nanodiscs), multilamellar 
vesicles comprised of saturated lipids, and multilamellar vesicles comprised of unstaturated 
lipids. Multilamellar vesicles comprised of POPC:ergosterol:AmB 10:1:1 were found to be both 
highly amenable to high resolution SSNMR analysis and physiologically relevant. Achieveing 
these two goals directly enabled the SSNMR studies discussed in Chapter 4.   
Nashrah Maryum contributed to the development of our protocol for preparation of 13C-
enriched AmB and  to the nanodisc studies. Prof. Rienstra, Mary Clay, Andy Nieuwkoop, 
Gemma Comellas, and Lindsey Sperling acquired the preliminary SSNMR data described in this 
chapter. 
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3-1 BACKGROUND 
Our discovery that oxidation at the C41 position of AmB is not required for antifungal 
activity challenged the leading model for the AmB structural underpinnings of the AmB ion 
channel. This left us with two possible conclusions: 1) the presumed critical polar interaction 
between the C41 carboxylate and the C19 mycosamine is not required for channel self-assembly, 
and/or 2) ion channel formation is not required for the antifungal activity of AmB. To further 
probe these questions, we sought to structurally characterize the putative ion channel aggregate 
formed by AmB in the presence of lipid bilayers. To this end, we engaged in a collaboration with 
Prof. Chad Rienstra and several members of his group to employ SSNMR to study the structure 
of AmB in the presence of lipid bilayers.  
Over the last 20 years, SSNMR has emerged1,2 as a powerful technique for studying 
membrane proteins in phospholipid bilayers. Many research groups3,4,5 have successfully 
characterized membrane-embedded proteins by SSNMR. The Rienstra group has pioneered new 
techniques that have helped drive these advances, and demonstrated the unique capabilities of 
SSNMR to structurally characterize various membrane proteins including alpha-synuclein,6 
bacteriorhodopsin,7 and cytochrome P450 3A4.8   
In contrast, there are relatively few examples of SSNMR studies of membrane-bound 
small molecules, although several recent examples have been reported for liposome-bound 
estradiol,9 cholesterol,10 anandamide,11 and cisplatin.12 Most pertinent to the work described in 
this chapter, a series of SSNMR studies of AmB in the presence of lipid bilayers has been 
reported by Murata and coworkers.13,14,15 These studies were reviewed in Chapter 1; key results 
and limitations of these studies will be described in detail below.  
The initial REDOR studies reported by Murata and coworkers were performed in 
DSPC,13 DMPC,13 and DLPC14 MLVs devoid of cholesterol. The key results of these 
investigations are depicted in Figure 3-1, with dephased nuclei of AmB shown in red. When 
short lipids were used (DLPC, DMPC), the pattern of REDOR dephasing at C39, C40, and C41 
was interpreted as evidence for a single pore channel. When the longer DSPC was used, only 
C41 was dephased by phosphorus, and this was interpreted as evidence for a double pore channel. 
In the case of the AmB/DLPC system (Figure 3-1A), U-13C-AmB was used, and a lack of 
observed dephasing for the middle portion of the molecule was interpreted so as to rule out the 
possibility that AmB was surface-bound. However, as will be demonstrated in Section 3-4, the 
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chemical shifts for the middle portion of AmB have a high amount of overlap, and cleanly 
interpreting results for these regions of the spectrum can be complicated.  
As described in chapter 1, three further limitations with these experiments are noteworthy. 
First, the lipid system was devoid of sterol, yet AmB is known to manifest its biological activity 
only in membranes containing sterols. Second, the lipids used in these studies were fully 
saturated, whereas biological membranes contain a substantial proportion of unsaturated lipids.15 
As described below, this distinction has important biophysical consequences that impact the 
activity of AmB. Finally, the use of C12 acyl chains (DLPC), which are rarely observed in 
natural systems, raises further questions regarding the physiological relevance of these findings. 
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Figure 3-1. Visual depiction of REDOR dephasing and subsequent interpretation. A) In the presence of DMPC or 
DLPC (no sterol present), the nuclei shown in red are moderately dephased. This was interpreted as evidence for a 
single pore membrane-spanning channel, depicted schematically with red arrows indicating sites of REDOR 
dephasing. B) When longer DSPC lipids are used, only C41 (red) is moderately dephased. This was interpreted as 
evidence for a double pore channel, shown schematically as in A. 
 
 The Murata group also recently reported 13C-19F REDOR studies of 14-fluoro-AmB and 
a skipped 13C-labeled ergosterol (3.1, Figure 3-2) in POPC MLVs.16 These experiments revealed 
dephasing of ergosterol C21, C26, C27, and C19 in the presence of 14-fluoro-AmB (Figure 3-2). 
In addition, 13C-31P REDOR revealed dephasing of ergosterol C26 and C27 by 31P of POPC. 
Viewed through the lens of the leading ion channel model for the mechanism of action of AmB 
and the previously described REDOR studies in saturated lipids, it was concluded based on these 
latest REDOR results that the AmB ion channel is comprised of both “head-to-head” and “head-
to-tail” orientation of AmB and ergosterol.  Importantly, however, the 13C-31P REDOR 
experiments that were previously performed in saturated lipids devoid of ergosterol.were not 
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repeated in this POPC based system. Also significantly, to the best of our knowledge, direct 13C-
31P REDOR dephasing between AmB and POPC has not been reported.  
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Figure 3-2. Shown at right is the skipped 13C-labeled ergosterol used for 13C-19F REDOR experiments. At left, green 
spheres indicate nuclei dephased by 19F. The authors proposed both head-to-tail and head-to-head interactions of 
AmB with ergosterol.    
As described above, we recognized limitations with the aforementioned studies that 
complicated interpretation of the reported results. Most importantly, no functional validation of 
the liposome system was reported. In particular, the MLVs composed of saturated lipids (DMPC, 
DLPC, DSPC) contained no sterol. The functional relevance of studying AmB in this type of 
system remains controversial. As described below, POPC/AmB/Ergosterol MLVs have been 
found to be a physiologically relevant bilayer system. However, interpreting these data through 
the lens of the prior studies with saturated lipids complicates data interpretation.  
Given all of the above, we decided to take a fresh look at this problem. We judged that to 
generate physiologically meaningful results via SSNMR, three goals needed to first be 
accomplished:  1) gain access to highly 13C-enriched AmB, 2) develop a physiologically relevant 
phospholipid bilayer system compatible with high resolution SSNMR studies with AmB, and 3) 
complete de novo assignments of 13C spectrum of AmB.   
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Research in our laboratories has extensively studied the biophysical properties of AmB in 
a variety of lipid environments. In parallel with the work discussed in this chapter, Palacios et 
al.17 and Gray et al.18 made several important discoveries which strongly impacted the course of 
the AmB SSNMR project. 
Palacios et al. conducted extensive biophysical assays on AmB, MeAmB, AmdeB, and 
MeAmdeB. In the context of isothermal titration calorimetry studies of these 4 compounds, a 
direct binding interaction was discovered between AmB and ergosterol. MeAmB also binds 
directly to ergosterol, whereas AmdeB and MeAmdeB (lacking a mycosamine appendage) do 
not bind ergosterol. This binding interaction was found to be critical for AmB channel activity in 
K+ efflux studies of AmB channel activity. Figure 3-3 depicts the K+ efflux from S. cerevisiae 
cells and egg-yolk phosphocholine/Ergosterol liposomes upon addition of AmB, MeAmB, 
AmdeB, or MeAmdeB. Based on these results, we envisioned that ergosterol-dependent K+ 
efflux from liposomes could serve as a measure of functional relevance of liposome systems 
under investigation for potential use in SSNMR of AmB (see below for details). 
 
Figure 3-3. K+ efflux from S. cerevisiae (A) and egg-yolk phosphochline liposomes (B) in the presence of AmB, 
MeAmB, AmdeB, and MeAmdeB. Each compound was added as a DMSO solution at the timepoints indicated, and 
efflux is reported as a percentage of maximum K+ relase induced by the addition of Triton X-100 to the system. 
Adapted from Palacios, et al. Proc. Natl. Acad. Sci. USA 2011, 108, 6733-6738 Copyright 2011, National Academy 
of Sciences. 
In the context of studying the biophysical properties of C35-deoxy-AmB, Gray et al. 
discovered that this molecule directly binds ergosterol, has no capability to form ion channels, 
and yet retains antifungal activity, albeit less potent, against both S. cerevisiae and C. albicans. 
Therefore, channel activity is not the primary mechanism of AmB antifungal activity, although it 
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does contribute to its potency. These discoveries allowed us to expand from a narrow focus of 
studying the AmB ion channel by SSNMR to a broader focus of studying the structural 
underpinnings of AmB binding to phospholipid bilayers and sequestering ergosterol.  
In addition to these discoveries, Gray et al. found that the amount of AmB at its MIC is 
greater than the total amount of lipid present in fungal cells. This fact became very important in 
our investigations of liposomes for SSNMR analysis of AmB. Prior to this breakthrough, we had 
assumed that minimizing the amount of AmB in liposome systems was important for minimizing 
its potential to aggregate. In light of this discovery, however, we were confident that using 
greater amounts of AmB in our liposomes would be functionally relevant. The remainder of this 
chapter will detail our efforts in accomplishing the 3 goals articulated above: 1) developing a 
reproducible method for the preparation of highly 13C-enriched AmB, 2) discovery of a 
functionally relevant lipid milieu for SSNMR analysis of AmB, and 3) de novo chemical shift 
assignments of U-13C AmB. 
3-2 PREPARATION OF HIGHLY ENRICHED 13C-LABELED AMPHOTERICIN B 
To study AmB by SSNMR we first needed a robust and reproducible method for the 
production of uniformly 13C-labeled AmB (U-13C AmB). Murata prepared this molecule for his 
REDOR studies via biosynthesis14 from the producing bacterium Streptomyces nodosus, using a 
modification of the medium originally reported by McNamara et al.19 for biosynthesis of tri-13C 
AmB.  Murata’s modification involved simply substituting 13C-labeled glucose (U-13C Glc) for 
natural abundance glucose in the culture medium. However, the medium also employs a large 
amount of natural abundance fructose. As a result, the 13C incorporation into the AmB scaffold is 
only ~15% using this method. While our preliminary SSNMR experiments using 15% enriched 
U-13C-AmB yielded spectra of satisfactory sensitivity, large amounts of instrument time were 
required to obtain these spectra. From these preliminary results it was clear we would need 
access to highly enriched U-13C-AmB, the availability of which would enable 2 aspects of our 
SSNMR studies. First, highly enriched U-13C AmB would maximize the number and types of 
potential SSNMR experiments we could perform.  Second, highly enriched U-13C-AmB would 
maximize sensitivity and thereby minimize instrument time required for our data acquisition. 
The high cost of uniformly 13C-labeled fructose prohibited a direct substitution for natural 
abundance fructose in the culture medium. A change in culture medium was not likely to be 
successful–McNamara et al. found that other media yielded no 13C incorporation. We considered 
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the possibility that streptomycetes simply convert fructose to glucose and that these bacteria 
could thus grow in the absence of fructose. Indeed, Lapidot20 has studied sugar metabolism in S. 
parvalus, and determined that fructose is directly converted to glucose by this bacterium. We 
experimented with growth conditions for S. nodosus in which U-13C Glc is substituted for natural 
abundance fructose in the culture medium. Gratifyingly, this simple substitution yielded U-13C-
AmB with average isotope incorporation estimated at ~85% by ESI mass spectrometry, the 
highest incorporation reported to date for this natural product. With this highly enriched AmB in 
hand, we had accomplished the first of the three goals outlined above. 
3-3 DISCOVERY OF A FUNCTIONALLY VALIDATED LIPID BILAYER PLATFORM 
FOR SSNMR ANALYSIS OF AMPHOTERICIN B 
Our second goal was to discover a functionally validated lipid platform for our SSNMR 
studies. We identified 3 essential criteria for such a lipid platform: 1) AmB will stably 
incorporate into the phospholipid bilayer, 2) the lipid platform retains ergosterol-dependent 
channel formation as judged by K+ efflux assays, and 3) the lipid platform will permit de novo 
assignment of AmB 13C chemical shifts. We investigated the use of nanodiscs, fully saturated 
phospholipid liposomes, and POPC liposomes for fulfillment of these 3 criteria. These 
investigations are described in the following 3 sections.     
3-3A INVESTIGATION OF NANOSCALE DISCOIDAL PHOSPHOLIPID BILAYERS 
AS A MILIEU FOR SSNMR STUDIES OF AMPHOTERICIN B 
Nanoscale discoidal lipid bilayers, “nanodiscs,” recently discovered by Sligar and 
coworkers21 were an attractive option for our studies. Nanodiscs consist of a membrane scaffold 
protein (MSP), a recombinant derivative of human apolipoprotein A-I, which acts as a “belt” 
encircling a planar patch of phospholipid bilayer. The MSP controls the size of each disc, and 
nanodiscs thus have a very narrow and reproducible size distribution.  
Sligar has demonstrated remarkable utility of nanodiscs for the study of membrane 
proteins, which are notorious for their poor solubility and propensity to aggregate. Use of 
nanodiscs has overcome both these limitations for many membrane proteins: the Sligar lab has 
successfully employed nanodiscs to study bacteriorhodopsin, cytochorome P450 3A4 (CYP3A4), 
β2-adrenergice receptors, and others.22 Notably, the Rienstra lab in collaboration with the Sligar 
lab has demonstrated that nanodisc-embedded membrane proteins are amenable to SSNMR 
analysis. They recently reported SSNMR studies of nanodisc-embedded CYP3A4.8 Importantly, 
CYP3A4 retains its active, folded state within the nanodisc.  
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Despite the success of nanodiscs in the study of membrane proteins, the use of nanodiscs 
for the study of membrane-embedded small molecules has not been demonstrated. Interestingly, 
study of AmB has historically been challenging due to the same limitations described above for 
membrane proteins: poor solubility and propensity for aggregation. AmB has poor solubility in 
all solvents except DMSO and DMF, and it is notorious for its capacity to aggregate in solution 
and in lipid bilayers. We envisioned that nanodiscs could overcome these limitations and allow 
us to study membrane-bound AmB assembled into discrete ion channels within the nanodiscs.  
Bolstered by the success of Sligar’s nanodisc platform for studying membrane proteins, 
we began a search for conditions to incorporate AmB into nanodiscs for subsequent SSNMR 
analysis. Our investigations of nanodiscs focused on the DPPC nanodiscs reported by the Sligar 
lab.21 These nanodiscs are reported to be 9-10 nm in diameter (depending on the method used to 
analyze their size). We anticipated these nanodiscs could comfortably accommodate the AmB 
ion channel with an estimated outer diameter of approx. 3 nm (measured using MOE with a 
channel structure similar to that reported by McCammon and coworkers).  We investigated 3 
strategies for preparation of nanodisc-embedded AmB:  
1. External addition: Formation of empty nanodiscs followed by addition of AmB 
2. Pre-incorporation: Pre-mixing of AmB with all nanodisc components, followed by 
dialysis to form nanodiscs 
3. Nanodiscs from liposomes: Formation of AmB-impregnated liposomes followed by 
addition of MSP to form nanodiscs 
In each case, size exclusion chromatography (SEC) was performed to measure the size and 
homogeneity of the resulting nanodiscs.  
External addition. As reported by Sligar, nanodiscs are prepared by the "detergent 
dialysis method."23 In this method, MSP and phospholipid are combined in the appropriate molar 
ratio and solubilized as mixed micelles with sodium cholate. As the cholate is removed by 
dialysis, the remaining MSP and phospholipid form nanodiscs. The size and homogeneity of the 
nanodiscs can then be analyzed by SEC. In addition, nanodiscs have been shown to contain a 
highly reproducible number of phospholipid molecules, thus allowing for addition of AmB at 
defined ratios of phospholipid to AmB.  
For our studies, we first prepared DPPC nanodiscs and analyzed them by SEC. We 
successfully reproduced Sligar's results, with the size of our nanodiscs measured by SEC to be 
9.5 nm in diameter based on a calibration against proteins of known size (see Figure 3-4).   
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Figure 3-4. Size exclusion chromatogram of blank DPPC nanodiscs. The retention time of 32.7 min was calculated 
to correspond to a size of 9.5 nm, based on column calibration with proteins of known size. 
We next formed nanodiscs containing DPPC and ergosterol, and AmB dissolved in DMSO was 
added to the nanodisc solution. SEC of the resulting solution revealed that the majority of AmB 
and MSP elute at a retention time corresponding to the void volume of the column (approx. 21.6 
min, see Figure 3-5).  
 
Figure 3-5. Size exclusion chromatogram of DPPC/AmB/Ergosterol nanodiscs prepared by external addition of 
AmB. AmB (λ = 406 nm) and the majority of MSP (λ = 280 nm) co-elute as a large aggregate at the retention time 
corresponding to the void volume for the column (approx. 21.6 min). 
Pre-incorporation. Sligar and coworkers have reported a method24 for preparation of 
nanodisc-embedded membrane proteins which involves solubilizing the protein with sodium 
cholate in the presence of all nanodisc components prior to nanodisc formation. Dialysis of 
cholate produces nanodisc-embedded membrane proteins. We investigated the possibility of 
forming AmB-impregnated nanodiscs via this pre-incorporation method.  Solubilizing MSP, 
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DPPC, ergosterol, and AmB in this manner consistently yielded large aggregates of AmB that 
eluted at the void volume along with MSP (see Figure 3-6).  
 
Figure 3-6. Size exclusion chromatogram of DPPC/AmB/Ergosterol nanodiscs prepared by the pre-incorporation. 
Note the large aggregate of AmB and MSP which elutes at the void volume. 
Nanodiscs from liposomes. Given that AmB is known to bind stably to liposomes,17 we 
attempted to form AmB-impregnated nanodiscs by the addition of MSP to AmB-impregnated 
MLVs (a similar method23 has been reported for formation of discoidal HDL-like particles from 
liposomes using apoliporproteins). We envisioned that MSP would disrupt the AmB-
impregnated liposomes and form nanodiscs containing embedded AmB. We were again 
disappointed to discover that AmB simply formed large aggregates eluting at the void volume 
(data not shown). This result is similar to that observed by Ryan and coworkers25 who similarly 
observed a large aggregate after addition of recombinant apolipoprotein A-I to AmB-
impregnated liposomes. 
Summary of nanodisc studies. Based on the studies described above, nanodiscs did not 
meet our first criterion of stable binding/incorporation of AmB. While isolation of the AmB ion 
channel within nanodiscs remains an intriguing possibility, our results indicate that this will 
require extensive screening of conditions for AmB incorporation. We thus turned our attention to 
investigations of liposomes as a potential lipid milieu for SSNMR studies of AmB. 
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3-3B INVESTIGATIONS OF LIPOSOMES COMPOSED OF FULLY SATURATED 
LIPIDS FOR SSNMR STUDIES OF AMPHOTERICIN B 
As noted above, Palacios et al.17 discovered the direct binding interaction between AmB 
and ergosterol in liposomes and showed that binding ergosterol was critical for channel 
formation in liposome K+ efflux studies. As a result of these discoveries, we were confident that 
liposomes could provide a suitable lipid milieu for SSNMR studies of AmB. Liposomes 
represent a diverse platform that has long been used for studies of membrane biophysics,23 
particularly for the study of membrane proteins. SSNMR has been applied to the study of various 
liposome-bound proteins by several research groups,2,3,4,5 including the Rienstra group. In 
contrast, there are relatively few examples of SSNMR studies of liposome-bound small 
molecules, but several examples have been reported. As discussed above, SSNMR analysis of 
liposome-bound AmB has been reported by Murata, and SSNMR has also been applied to the 
study of liposome-bound estradiol,9 cholesterol,10 anandamide,11 and cisplatin.12  
The diversity of the liposome platform stems from the fact that virtually any phospholipid 
or combination of phospholipids has the capacity to form liposomes. The biophysical properties 
of liposomes are intimately tied to the physical properties of the lipids from which the liposomes 
are formed. Membrane properties can thus be fine-tuned for a variety of applications.. 
Ergosterol-dependent K+ efflux provided a metric whereby we could functionally validate the 
relevance of our liposomes. Thus, the ideal liposome system for AmB would retain ergosterol-
dependent channel formation and would also be amenable to SSNMR.  
To measure AmB-induced K+ efflux from lipoosomes, large unilamellar vesicles (LUVs) 
containing 150 mM KCl are prepared and dialyzed against 150 mM NaCl. A K+-selective 
electrode is then used to measure K+ efflux upon addition of AmB dissolved in DMSO. We 
screened liposomes of various compositions for AmB K+ efflux activity both in the presence and 
absence of ergosterol. LUVs composed of DPPC exhibit robust K+ efflux activity irrespective of 
the presence of ergosterol (Figure 3-7A). Similar results were observed for DLPC, DMPC, and 
DSPC (data not shown). Mixtures of DPPC/POPC yield only moderate differences in K+ efflux 
for the plus-ergosterol and minus-ergosterol states (Figure 3-7B). Thus, we concluded that 
saturated lipids did not satisfy the criterion of ergosterol-dependent efflux activity. 
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Figure 3-7. A) AmB initiates K+ efflux from 200 μM LUVs composed of DPPC plus 10% ergosterol (black 
squares) and minus ergosterol (open squares). B) Similar activity is observed for 75:25 POPC:DPPC plus 1% 
ergosterol (black triangles) and minus ergosterol (open triangles). In both A and B, AmB was added as a DMSO 
solution at t = 1.5 min, and efflux is reported as a percentage of total efflux observed upon addition of Triton X-100 
at t = 6.0 min. 
3-3C INVESTIGATIONS OF LIPOSOMES COMPOSED OF POPC FOR SSNMR 
STUDIES OF AMPHOTERICIN B 
We also investigated the use of POPC as the sole phospholipid in our liposomes. POPC is 
composed of a choline head group, one saturated palmitoyl chain, and one monounsaturated 
oleoyl chain. Thus, POPC forms bilayers composed of 50:50 saturated:unsaturated lipids, a ratio 
similar to that observed in physiologic membranes15 (egg yolk phosphocholine, for example is 
primarily composed of POPC).21 For these reasons, POPC has been very widely used as a 
phospholipid to form membranes in biophysical studies. When POPC liposomes were tested for 
K+ efflux activity, strongly ergosterol-dependent K+ efflux activity was observed (Figure 3-8).  
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Figure 3-8. AmB initiates K+ efflux from 200 μM LUVs composed of POPC plus 10% 
ergosterol (closed diamonds) and minus ergosterol (open diamonds). AmB was added as a 
DMSO solution at t = 1.5 min, and efflux is reported as a percentage of total efflux observed 
upon addition of Triton X-100 at t = 6.0 min.  
The ergosterol-dependence of K+ efflux activity in POPC LUVs was observed over a range of 
AmB concentrations, from 1000:1 lipid:AmB to 10:1 lipid:AmB (Figure 3-8 and Figure 3-9). To 
maximize sensitivity in our NMR experiments, we opted to use 10:1:1 POPC:U-13C-
AmB:Ergosterol. As noted above, 10 mol% AmB (relative to POPC) is significantly lower than 
the amount of AmB present at the MIC of AmB. Thus, this ratio achieved a balance between 
biolgocial relevance, maximizing sensitivity, and minimizing the amount of valuable U-13C-
AmB that would be required to make each sample. With this 10:1:1 POPC:AmB:Ergosterol 
liposome in hand, we proceeded to evaluate the potential of this system to provide SSNMR data 
of sufficient quality to allow for unambiguous de novo 13C chemical shifts assignemtns for U-
13C-AmB. 
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Figure 3-9. Ergosterol-dependent K+ efflux from LUVs composed of POPC/AmB 1000:1 plus ergosterol 
(closed triangles) and minus ergosterol (open triangles); POPC/AmB 100:1 plus ergosterol (closed squares) 
and minus ergosterol (open squares), and POPC/AmB 50:1 plus ergosterol (closed diamonds) and minus 
ergosterol (open diamonds). AmB was added at t = 1.5 min, and efflux is reported as a percentage of total 
efflux observed upon addition of Triton X-100 at t = 6.0 min. 
3-4 DE NOVO 13C CHEMICAL SHIFT ASSIGNMENTS OF U-13C-AMPHOTERICIN B 
POPC liposomes met our first 2 requirements of a suitable lipid milieu for SSNMR of 
AmB. Our final requirement was the successful completion of de novo 13C chemical shift 
assignments of U-13C-AmB. For this purpose, an MLV sample comprised of 10:1:1 POPC:U-
13C-AmB:Ergosterol was prepared. We then acquired a series of two-dimensional 13C-13C 
dipolar-assisted rotational resonance (DARR)26 and double quantum filtered (DQF)27 spectra. 
Since only the AmB in our samples was 13C-enriched, 13C-13C spectra allow for analysis of 
interactions between 13C-13C nuclei of AmB without interference from lipid and/or ergosterol 
signals (for natural abundance molecules, the probability that 2 adjacent carbon atoms are both 
13C is 0.0001). The DARR experiment gives rise to crosspeaks between 13C nuclei interacting 
through space via dipolar coupling. When mixing time is short, only correlations for those nuclei 
very close to one another are observed, i.e. one- and two-bond correlations. At longer mixing 
times, more crosspeaks are observed, and long range interactions are observed. Figure 3-10 
depicts the DARR spectrum of U-13C-AmB with 50 ms mixing.  
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Figure 3-10. 13C-13C DARR spectrum of AmB with 50 ms mixing. 
Examining the structure of AmB, several nuclei are predicted to fall in unique regions of 
the spectrum: C1 and C41 carbonyls (160-180 ppm), C38, C39, C40, and C6' methyls (10-25 
ppm), C13 hemiketal and C1' acetal (95-105 ppm). These resonances were striaghtforward to 
assign, and by following the pattern of crosspeaks through the spectrum, approximately 50% of 
the resonances were assigned confidently (not counting the polyene, the chemical shifts of which 
are not sufficiently resolved to make any site-specific assignments). Further examination of the 
non-polyene portion of AmB reveals predominantly a repeating pattern of 1,3-diols, with 
methylenes intervening. The chemical shifts for the methane carbons bearing these hydroxyl 
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groups fall between 70 and 90 ppm, and those of the methylene carbons fall between 30 and 60 
ppm. Hence, this region of the spectrum (~75 ppm x ~45 ppm) is very crowded. We also noted 
some 2 bond correlations even at this short mixing time, thus further crowding the spectrum.  
To allow assignment of the remaining resonances with high confidence, we employed 
DQF spectra to reduce the number of crosspeaks in the spectrum. In this experiment, only one-
bond correlations between adjacent 13C nuclei are observed due to filtering of single-quantum 
transitions in the pulse sequence. The DQF spectrum of U-13C-AmB is shown in Figure 3-11. 
We noted that this spectrum contained more peaks than would be predicted if every bonded pair 
gave rise to just one crosspeak. From DQF spectra, assignments of the non-polyene 13C 
resonances of AmB were completed, and we noted that the extra crosspeaks form a second, and 
in some cases a third, series of assignments. One set of assignments was clearly dominant, and 
these primary assignments were used for subsequent studies.  As an example of the multiple 
assignments for AmB from this spectrum, Figure 3-12 depicts the crosspeaks for the 
mycosamine sugar. Two sets of assignments (with colored labels for differentiation) are clearly 
found. While one set was assigned as the primary assignment, these multiple assignments 
provide direct evidence that AmB does not exist in a homogeneous chemical environment within 
liposomes. Furthermore, mycosamine has rotational degrees of freedom about its glycosidic 
attachment to the macrolactone, and these assignments potentially represent multiple 
configurations about this linkage. Further studies will be required to elucidate the significance of 
these secondary assignments. Figure 3-13 depicts the structure of AmB with all assignments that 
could be unambiguously determined from DQF spectra, with confirmation from 2- and 3-bond 
correlations from DARR spectra. These assignments are also found in Table 3-1.  
With the completion of de novo 13C assignments for AmB, POPC MLVs now met our 3 
criteria to qualify as a suitable lipid system for SSNMR: AmB readily binds to these MLVs, the 
vesicles retain ergosterol-dependent K+ efflux activity, and we successfully completed de novo 
assignments of U-13C-AmB in this lipid system. Moreover, we had accomplished the three goals 
defined in section 3-1:  1) developing a reproducible method for the preparation of highly 13C-
enriched AmB, 2) discovery of a functionally relevant lipid milieu for SSNMR analysis of AmB, 
and 3) de novo chemical shift assignments of U-13C AmB. We were thus poised to proceed with 
the SSNMR studies described in Chapter 4. 
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Figure 3-11. DQF spectrum of AmB.  
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Figure 3-12. Two complete sets of assignments were identified for the mycosamine 
sugar, possibly indicating multiple configurations about the glycosidic linkage to the 
macrolactone.  
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Figure 3-13. AmB 13C chemical shift assignments. When multiple assignments were made for a given site, 
all assignments are listed, with the value closest to the atom itself representing the primary assignment. 
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 δ (ppm) 
Carbon Major Minor Minor 
1 176 174.9  
2 45.3 43.4  
3 66.6 72.9  
4 48.7 43.5  
5 74.2   
6 35.9   
7 37.9   
8 78.9   
9 77.7   
10 41.7 43.3  
11 71.5 70.9  
12 49.4 52.1  
13 99.7 101  
14 48.4 47.1  
15 68.6 66.6  
16 61.3   
17 71.5   
18 43.6   
19 79.3   
34 48.3   
35 83.7 79.2  
36 43.4 42.7  
37 74.4 72.4  
38 22.1 22.9  
39 15.4 14.7  
40 25 25.6  
41 184.9   
    
1' 98.6 104.2 106.3 
2' 67.4 71.6  
3' 57.1 59.7  
4' 69.8 70.6  
5' 76.3 76.9  
6' 19.9   
 
Table 3-1. AmB 13C chemical shift assignments.  
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3-5 EXPERIMENTAL SECTION 
I. Nanodisc preparation and SEC analysis. Membrane scaffold protein was expressed from e. 
coli and nanodisc samples prepared and analyzed according to the methods reported by Sligar 
and coworkers. 21,24 
 
II. Preparation of U-13C-AmB.  
U-13C-Glc (Cambridge Isotopes, Cambridge, MA) was substituted for fructose in the medium 
reported by McNamara and coworkers.19 The procedure reported by Murata for preparing U-13C-
AmB14 was followed. Due to the slow-growing nature of streptomycetes and the resulting ease 
with which cultures can be contaminated, all manipulations with cell cultures were carried out in 
a Labconco Clean Bench sterilized with 70% EtOH before and after manipulations. 20 mL 
cultures in 250 mL baffled flasks were used. For pulse feeding of glucose, 140 uL of 50% w/v U-
13C-Glc were added to each baffled flask. 
 
After work-up of the U-13C-AmB, if there remained any sign of Aliquat 336 (dark yellow solid, 
sticky solid, not free flowing), then this material was further purified via C18 reverse phase flash 
chromatography as follows: AmB was dissolved in DMF and Celite 545 was added to form a 
slurry. AmB was concentrated onto the Celite in vacuo, and the resulting Celite was loaded onto 
a C18 flash column equilibrated with 20% MeCN / 5 mM ammonium aceate. Purification with a 
gradient of 20% MeCN / 5 mM ammonium acetate to 100% MeCN followed by 100% Optima 
MeOH. This material could then be safely HPLC purified. If signs of Aliquat 336 still remained, 
the material was purified again by C18 flash column.  
 
U-13C-AmB was HPLC-purified using a Waters SunFire Prep C18 OBD 30x150 mm column 
with a gradient of 5% to 65% MeCN / 5 mM ammonium acetate over 12 minutes. Post-column, 
solvent was removed in vacuo and the solid was suspended via bath sonication in 1:1 
acetonitrile:toluene and concentrated in vacuo to azeotrope residual acetic acid.   
 
K+ efflux assays. 
General Information. 
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These experiments were carried out by the method reported by Gray et al.17 and Palacios et al.,18 
with a small modification when saturated lipids (such as DPPC) were used (see below). Ion 
selective measurements were obtained using a Denver Instruments (Denver, CO) Model 225 pH 
meter equipped with a World Precision Instruments (Sarasota, FL) potassium selective electrode 
inside a Faraday cage. The electrode filled with 1000 ppm KCl standard solution and conditioned 
in a 1000 ppm KCl standard solution for 30 minutes prior to ion selective measurements. 
Measurements were made on 3 mL solutions that were magnetically stirred in 7 mL Wheaton 
vials incubated in a 30 °C aluminum block (S. cerevisiae) or at 23 °C (LUVs). The instrument 
was calibrated daily with KCl standard solutions to 10, 100, and 1000 ppm potassium.  The 
potassium concentration was sampled every 30 seconds throughout the course of the efflux 
experiments. 
 
Data Analysis. 
The data from each run was normalized to the percent of total potassium release, from 0 to 100%. 
Thus for each experiment a scaling factor S was calculated using the following relationship: 
 
 
 
Each concentration data point was then multiplied by S before plotting as a function of time.  
Efflux from 10% ergosterol LUVs. 
 
LUV Preparation. 
Phospholipids were obtained as a stock solution in CHCl3 from Avanti Polar Lipids (Alabaster, 
AL) and was stored at -20 °C under an atmosphere of dry argon and used within 3 months. A 4 
mg/mL solution of ergosterol in CHCl3 was prepared monthly and stored at 4 °C under an 
atmosphere of dry argon. Prior to preparing a lipid film, the solutions were warmed to ambient 
temperature to prevent condensation from contaminating the solutions. A 13 x 100 mm test tube 
was charged with 640 μL POPC and 230 μL of the ergosterol solution. The solvent was removed 
with a gentle stream of nitrogen and the resulting lipid film was stored under high vacuum for a 
minimum of eight hours prior to use. The film was then hydrated with 1 mL of 150 mM KCl, 5 
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mM HEPES pH 7.4 (K buffer) and vortexed vigorously for approximately 3 minutes to form a 
suspension of multilamellar vesicles (MLVs). The resulting lipid suspension was pulled into a 
Hamilton (Reno, NV) 1 mL gastight syringe and the syringe was placed in an Avanti Polar 
Lipids Mini-Extruder. For saturated lipids with high temperature phase transitions, this was done 
on a heating block above the transition temperature of the lipid. The lipid solution was then 
passed through a 0.20 μM Millipore (Billerica, MA) polycarbonate filter 21 times, the newly 
formed large unilamellar vesicle (LUV) suspension 
being collected in the syringe that did not contain the original suspension of MLVs to prevent the 
carryover of MLVs into the LUV solution. To obtain a sufficient quantity of LUVs, three 
independent 1 mL preparations were pooled together for the dialysis and subsequent potassium 
efflux experiments. The newly formed LUVs were dialyzed using Pierce (Rockford, IL) Slide-A-
Lyzer MWCO 3,500 dialysis cassettes.  The samples were dialyzed three times against 600 mL 
of Na buffer. The first two dialyses were two hours long, while the final dialysis was performed 
overnight. 
 
Determination of Phosphorus Content. 
Determination of total phosphorus was adapted from the report of Chen and coworkers.9  The 
LUV solution was diluted tenfold with Na buffer and three 10 μL samples of the diluted LUV 
suspension were added to three separate 7 mL vials. Subsequently, the solvent was removed with 
a stream of N2. To each dried LUV film, and a fourth vial containing no lipids that was used as a 
blank, was added 450 μL of 8.9 M H2SO4. The four samples were incubated open to ambient 
atmosphere in a 225 °C aluminum heating block for 25 min and then removed to 23 °C and 
cooled for 5 minutes. After cooling, 150 μL of 30% w/v aqueous hydrogen peroxide was added 
to each sample, and the vials were returned to the 225 °C heating block for 30 minutes.  The 
samples were then removed to 23 °C and cooled for 5 minutes before the addition of 3.9 mL 
water. Then 500 μL of 2.5% w/v ammonium molybdate was added to each vial and the resulting 
mixtures were then vortexed briefly and vigorously five times. Subsequently, 500 μL of 10% w/v 
ascorbic acid was added to each vial and the resulting mixtures were then vortexed briefly and 
vigorously five times. The vials were enclosed with a PTFE lined cap and then placed in a 
100 °C aluminum heating block for 7 minutes. The samples were removed to 23 °C and cooled 
for approximately 15 minutes prior to analysis by UV/Vis spectroscopy. Total phosphorus was 
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determined by observing the absorbance at 820 nm and comparing this value to a standard curve 
obtained through this method and a standard phosphorus solution of known concentration. 
 
Determination of Ergosterol Content. 
Ergosterol content was determined spectrophotometrically. The LUV solution was diluted 
tenfold with Na buffer, and 50 μL of the dilute LUV suspension was added to 450 μL 2:18:9 
hexane:isopropanol:water (v/v/v). Three independent samples were prepared and then vortexed 
vigorously for approximately one minute. The solutions were then analyzed by UV/Vis 
spectroscopy and the concentration of ergosterol in solution was determined by the extinction 
coefficient of 10400 L mol-1 cm-1 at the UVmax of 282 nm and was compared to the 
concentration of phosphorus to determine the percent sterol content. The extinction coefficient 
was determined independently in the above ternary solvent system. LUVs prepared by this 
method contained between 7 and 14% ergosterol. 
 
Efflux from LUVs. 
The LUV solutions were adjusted to 1 mM in phosphorus using Na buffer. 3 mL of the 1 mM 
LUV suspension was added to a 7 mL vial and the solution was gently stirred. The potassium 
ISE probe was inserted and data were collected for one minute prior to the addition of the 
compound. Then, 30 μL of a 0.1 mM, 1.0 mM, or 3.0 mM DMSO solution of the compound in 
question was added and data were collected for five minutes. Then to effect complete potassium 
release, 30 μL of a 10% v/v solution of triton X-100 was added and data were collected for an 
additional five minutes. The experiment was duplicated with similar results. 
 
SSNMR Experiments 
SSNMR Sample preparation 
HPLC purified U-13C-AmB was suspended in a large volume of Optima methanol, typically ~75 
mL for 10 mg. Using a Hamilton gastight syringe, 3 x 10 μL of this solution were diluted with 
Optima methanol to a final volume of 510 μL. The concentration of each resulting solution was 
calculated based on UV/Vis absorbance at 406 nm using ε = 146000 and the average 
concentration was used as the concentration of the original AmB stock solution. The appropriate 
volume of stock solution (typically 30-40 mL) was concentrated in vacuo to a small volume that 
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could then be transferred to a 7 mL Wheaton vial, with three methanol washes to ensure 
complete transfer. This resulting AmB suspension was concentrated in vacuo. Stock solutions of 
phospholipid and ergosterol in CHCl3 were added to the vial via Hamilton syringe along with an 
equivalent volume of Optima MeOH. This suspension was briefly vortexed and sonicated until 
no AmB remained on the sides of the vial (2-3 cycles). Solvent was removed under a gentle 
stream of nitrogen gas. Residual solvent was removed under high vacuum overnight.  
 
To the dried AmB/lipid film was added filter-sterilized 0.3 mM HEPES buffer, pH 7.0 to yield a 
final phospholipid concentration of 40 mM. This aqueous suspension was vortexed and sonicated 
3 times or until a homogeneous suspension was observed. Samples were then submitted to 5 
freeze/thaw cycles in liquid nitrogen followed by lukewarm tapwater. Samples were then frozen 
in liquid nitrogen a 6th time and placed in a lyophilizer for a minimum of 8 hours. The 
lyophilization chamber was then back-filled with dry argon to prevent samples from absorbing 
ambient water. Samples were immediately capped and packed into rotors for SSNMR as soon as 
possible.    
     
Dry samples were packed in 3.2 mm diameter SSNMR rotors and hydrated with 7-10 μL of 
MilliQ H2O. Rubber discs were used in the rotors to maintain hydration levels by creating a seal 
against which the rotor cap and drive tip were placed. Samples were placed at 4 °C for at least 24 
hours to allow water to equilibrate. 
 
SSNMR Experiments.  
MAS SSNMR experiments were performed at 600 MHz 1H frequency on Varian InfinityPlus 
spectrometers, with a 3.2-mm Varian 1H-13C-15N T3 probe at an MAS rate of 10 kHz. The 
temperature control point was set to 20 °C, and actual sample temperature of 19.5 °C for all 
experiments, as calibrated by ethylene glycol.28  All experiments utilized tangent ramped cross-
polarization (CP)29 with an average of 75 kHz SPINAL30,31 decoupling of protons applied during 
evolution and acquisition periods. A series of 13C-13C 2D spectra were acquired with 25 to 
500ms DARR, and double quantum filtered spectra were acquired using the SPC5 pulse 
sequence, with q = 30.27  Chemical shifts are referenced to adamantane.32 
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CHAPTER 4 
SSNMR studies of amphotericin B in the presence of phospholipid bilayers reveal that 
large, extramembranous aggregates of amphotericin extract ergosterol from the membrane 
 
ABSTRACT 
Our laboratories recently discovered that the antifungal activity of AmB involves two 
complementary mechanisms: sterol sequestration and membrane permeabilization. Of these two 
mechanisms, sterol sequestration was shown to be the primary mechanism of antifungal activity. 
However, the structural underpinnings of how AmB binds to membrane phospholipids and 
ergosterol remain unclear. To probe the primary location of AmB within the phospholipid bilayer, 
we conducted paramagnetic relaxation enhancement (PRE) SSNMR studies of membrane-bound 
AmB in the presence of 1-palmitoyl-2-stearoyl-(16-doxyl)-sn-glycero-3-phosphocholine (16-
DOXYL-PC) and 1-palmitoyl-2-stearoyl-(5-doxyl)-sn-glycero-3-phosphocholine (5-DOXYL-
PC). Three sets of PRE experiments were performed: 1) measurement of POPC PREs, 2) 
measurement of U-13C AmB PREs in the presence of these same lipids, and 3) measurement of 
13C-labeled ergosterol PREs at increasing ratios of AmB:ergosterol. The results of these 
experiments reveal that the majority of AmB is not embedded within the phospholipid bilayer 
but is instead bound to the bilayer as a large aggregate phase-separated from membrane 
phospholipids. In the presence of ergosterol, this large aggregate functions to bind and extract 
ergosterol from the phospholipid bilayer, thus acting as a "sponge" for ergosterol. These results 
indicate that AmB has greater proximity to water than to phospholipid. Based on all of these 
results, we propose a new model in which AmB exerts its antifungal activity primarily via self-
assembly into large, extramembranous aggregates that function as sponges for ergosterol, thus 
depleting fungal membranes of this physiologically vital lipid.  
Prof. Chad Rienstra, Mary Clay, and Gemma Commellas acquired the SSNMR data 
described in this chapter. Data were analyzed primarily by Mary Clay and the author.  Brice Uno 
assisted with purification of AmB and preparation of SSNMR samples. Alex Cioffi, Matt Endo, 
and Shu Wang assisted in preparation of 13C-labeled ergosterol. Alex Cioffi contributed to 
preparation of SSNMR samples containing 13C-labeled ergosterol. 
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4-1 BACKGROUND 
For nearly 40 years, the barrel stave ion channel model1,2,3 discussed in Chapter 1 has 
dominated the structural model for AmB (4.1) in the presence of lipid bilayers. Three major 
postulates form the basis for this model: 1) In phospholipid bilayers, AmB primarily exists as 
discrete, nanometer-scale barrel stave pores, 2) These pores are embedded in the phsopholipid 
bilayer, and 3) Ergosterol (4.2) binds to these embedded pores. To date, most of the structural 
studies of AmB, including many SSNMR experiments, have been interpreted almost exclusively 
through the lens of this inserted ion channel model. As discussed in Chapter 3, we have taken a 
fresh approach to this problem by preparing highly 13C-enriched AmB, identifying a functionally 
relevant lipid bilayer system for SSNMR analysis of membrane-bound AmB, and completing de 
novo AmB 13C chemical shift assignments. We were thus in a position to plan a suite of high 
resolution SSNMR experiments to study AmB in a phospholipid environment.  
Rather than focus our studies exclusively on the barrel stave ion channel model, we chose 
to focus our SSNMR experiments on simply elucidating interactions between AmB and 
membrane phospholipids As described in Chapter 3, work in our laboratories recently identified 
ergosterol sequestration as the primary mechanism of AmB antifungal activity.4 However, the 
structural and biophysical underpinnings of this unique small molecule-small molecule 
interaction remain unknown. Ergosterol is known to form a variety of functions in yeast 
membranes including enabling the proper functioning of membrane proteins,5 microdomain 
formation,6 vacuole fusion,7 endocytosis,8 and pheromone signaling9 
In light of our recent discovery that there is approximately 10 times more AmB than 
ergosterol at the MIC for AmB,4 we hypothesized that the primary significance of AmB binding 
ergosterol is to preclude ergosterol from performing its critical physiological functions in fungal 
membranes. We identified three possible models for how AmB carries out the task of 
sequestering ergosterol (Figure 4-1):  
1) The classic ion channel model (Figure 4-1A) in which ergosterol is bound 
between adjacent AmB molecules  
2) Surface adsorption model (Figure 4-1B) in which AmB binds to the hydrophilic 
portion of the lipid bilayer and sequesters ergosterol  
3) Sterol sponge model (Figure 4-1C) in which AmB binds to lipid bilayers as a 
large, extramembranous aggregate and extracts ergosterol from the lipid bilayer 
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We recognized that the key to differentiating these 3 models was determining the primary 
location of AmB within the lipid bilayer and the location of ergosterol in the absence and 
presence of AmB.  
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Figure 4-1. A) Structure of AmB and ergosterol. B) Classic barrel-stave model of the AmB ion channel. C) Surface 
adsorption model of AmB bound to ergosterol. D) Sterol sponge model wherein a large, phase-separated aggregate 
of AmB binds to the phospholipid bilayer and extracts ergosterol.  
 To do this, we performed a series of 13C paramagnetic relaxation enhancement (PRE)10,11 
studies of AmB and ergosterol in the presence of phospholipid bilayers containing lipids with 
appended nitroxyl spin labels: 1-palmitoyl-2-stearoyl-(16-doxyl)-sn-glycero-3-phosphocholine 
(16-DOXYL-PC 4.4) and 1-palmitoyl-2-stearoyl-(5-doxyl)-sn-glycero-3-phosphocholine (5-
DOXYL-PC 4.5). Unpaired electrons are known to dramatically decrease both the T1 and T2 
relaxation properties of proximal nuclei in NMR experiments.10,11 PRE studies in the presence of 
various paramagnetic probe reagents have been reported.12 
Paramagnetic phospholipids such as 4.4 and 4.5 have been used for a variety of EPR 
studies13 of membrane biophysics, but their use in SSNMR has been limited. Notably, Sankaram 
and Thompson14 employed SSNMR to determine the position of 13C-labeled cholesterol in DPPC 
MLVs containing 5% 5-DOXYL-PC. This method involves measuring DPPC PREs to determine 
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the effect of the nitroxyl spin-label at specific depths within the bilayer. Subsequently, 13C PREs 
of 13C-labeled cholesterol were measured and the position of cholesterol in the bilayer was 
determined.    
We recognized three advantages to this method for determining the position of AmB and 
ergosterol in the lipid bilayer. First, paramagnetic spin-labels have the unique capacity to perturb 
nuclei up to 24 Ǻ from the unpaired electron12 (in contrast, REDOR experiments have an upper 
limit of approximately 8-12 Ǻ,15 depending on the nuclei involved). Second, unlike REDOR, use 
of U-13C-AmB does not complicate analysis due to neighboring 13C nuclei. Third, in comparison 
to many other more complicated SSNMR experiments (such as REDOR), the PRE experiment is 
relatively straightforward and data can be acquired fairly quickly. We have adapted the method 
of Sankaram and Thompson for our purposes in studying AmB. We opted to use both 16-
DOXYL-PC 4.4 and 5-DOXYL PC 4.5 in parallel PRE studies to probe both the bilayer interior 
(16-DOXYL-PC) and the outer portion of the bilayer (5-DOXYL-PC) for AmB and ergosterol. 
This chapter details the use of these spin-labeled lipids to measure 13C PREs of AmB in 
POPC MLVs and the subsequent measurement of 13C PREs of ergosterol in the presence of 
increasing amounts of AmB. In stark contrast to the leading ion channel model, our results 
indicate that AmB primarily exists as large, phase-separated aggregates that function to extract 
ergosterol from the membrane (Fig. 4-1C.)   
4-2 PARAMAGNETIC RELAXATION ENHANCEMENT STUDIES OF POPC AND U-
13C AMPHOTERICIN B 
To assess the position of AmB within the phospholipid bilayer, we first needed to assess 
the PRE effects of 4.4 and 4.6 on POPC. Due to the unique location of the nitroxyl moiety in 
each of these compounds, this set of lipids allowed us to probe the entire bilayer for PRE effects. 
We probed the hydrophobic core with 16-DOXYL-PC, bearing a nitroxyl spin label near the end 
of the lipid acyl chain. We probed the outer portion of the bilayer with 5-DOXYL-PC, bearing a 
nitroxyl spin label near the acyl C1 carbonyl.  
To measure POPC PREs, we prepared three POPC MLV samples in parallel, each 
consisting of 10:1 POPC:ergosterol with 2 of the 3 samples each containing 5 mol% of either 4.4 
or 4.5. T1 values were measured by the inversion recovery method:16 a 180º pulse followed by a 
delay, τ, followed by a 90º pulse and acquisition. The τ delay is arrayed, and the magnetization 
following the 90º pulse varies with τ as  
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M(τ) = M(0)[1 – 2exp(–τ/T1)]        Eq. 4.1 
For each array, a series of spectra with varying intensities is produced, and integrations 
for any given peak vary exponentially according to Eq. 4.1. The integrations for each peak in the 
spectrum were fit to exponential curves to determine the T1. PREs were calculated by simply 
subtracting T1 values for the samples containing DOXYL-PCs from the corresponding T1 values 
in the control sample.  
The results of these PRE experiments were consistent with the predicted location of each 
nitroxyl spin label (Figure 4-2). Specifically, 16-DOXYL-PC (Figure 4-2A) gave rise to very 
strong PREs for those POPC nuclei near the bilayer center, with decreasing PREs as the distance 
from the bilayer center increased. 5-DOXYL-PC (Figure 4-2B) gave rise to strong PREs for 
nuclei in the outer and middle portion of the bilayer, with PREs decreasing toward the bilayer 
center.  
To probe the position of AmB within the bilayer, we next measured the PRE effect of 4.4  
and 4.5 U-13C AmB. Importantly, the 3 models presented in Figure 4-1 each lead to distinct 
predictions for these experiments. In the ion channel model (Fig. 4-1A), AmB is predicted to 
experience large PRE effects in the presence of both 16-DOXYL-PC and 5-DOXYL-PC, in the 
surface adsorption model (Fig. 4-1B) AmB is predicted to display large PRE effects only in the 
presence of 5-DOXYL-PC, and in the sterol sponge model, no PRE effects are expected for 
AmB in the presence of either membrane-embedded spin label.  
To measure the AmB PREs, three POPC MLV samples were prepared in parallel, each 
consisting of 10:1:1 POPC:U-13C AmB:ergosterol with two of the three samples containing 5 
mol% of either 4.4 or 4.5. Strikingly, in both cases, no significant PRE effects were observed for 
any 13C nucleus of AmB (Figure 4-2, D and E). These results strongly indicate that the majority 
of AmB is phase-separated from membrane phospholipids, thus existing far from and unaffected 
by the nitroxyl spin labels.   
 
 95
-0.5 0.5 1.5 2.5 3.5 4.5
41
40
37
36
35
34
20-33
16
13
11
9
8
5
4
1
3'
1'
A B
C D
± u13C AmB
O
O
MeHO
Me
Me
O
OHO
HO CO2
OH
OH
OH
OH
HO
O
OH
NH3
OHMe
± u13C AmB
-0.5 0.5 1.5 2.5 3.5 4.5
ω
ω-1
ω-2
(CH2)n
(CH2)n
C10
C9
C8/11
C3
C2
C10
G3
G2
G1
α
β
γ
-0.5 0.5 1.5 2.5 3.5 4.5
ω
ω-1
ω-2
(CH2)n
(CH2)n
C10
C9
C8/11
C3
C2
C10
G3
G2
G1
α
β
γ
-0.5 0.5 1.5 2.5 3.5 4.5
41
40
37
36
35
34
20-33
16
13
11
9
8
5
4
1
3'
1'
O
Me
O
O
O P
O
O
O
NMe3
O
Me
POPC
4.3
AmB
4.1
13C R1 (s-1)13C R1 (s-1)
13C R1 (s-1) 13C R1 (s-1)
 
Figure 4-2. 13C PRE effects in POPC/Ergosterol MLVs. A, B, and C depict POPC PRE effects in 
the presence of 5% 16-DOXYL-PC (A), 5-DOXYL-PC (B), and TEMPO-PC (C). The y-axis labels 
are arranged in order of depth within the bilayer. As predicted, 16-DOXYL-PC has the strongest effect 
at the termini of the ljpid acyl chains. 5-DOXYL-PC has the greatest effect in the middle, and 
TEMPO-PC has the greatest effect in the headgroup. D, E, and F depict AmB 13C PRE effects in the 
presence of 5% of each nitroxyl spin-labeled lipid. Only well resolved AmB resonances are reported.    
A second striking observation from our PRE data was the magnitude of T1 values of AmB 13C 
nuclei (Figure 4-3A). Notably, the majority of T1 values for the 13C of POPC are between 0.3 and 
0.5 s, while the T1s for AmB range from 3.0 to 4.5 s (Figure 4-3B). The much longer AmB T1 
values are suggestive of a large, immobile aggregate (see Section 4-5 for further discussion).  
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Figure 4-3. T1 relaxation values of AmB (left) and POPC (right). In most cases, AmB T1 values are nearly an 
order of magnitude longer than those of POPC, indicative of different motional properties for these 2 molecules.  
4-3 PARAMAGNETIC RELAXATION ENHANCEMENT OF 13C-LABELED 
ERGOSTEROL IN THE PRESENCE OF INCREASING AMOUNTS OF 
AMPHOTERICIN B 
To test the hypothesis that AmB extracts ergosterol from lipid bilayers, we designed a 
series of 13C PRE experiments using skipped 13C-labeled ergosterol 4.6 (hereafter 13C-Erg). As a 
critical lipid component of fungal cell membranes, ergosterol is intimately mixed with membrane 
phospholipids and is thus predicted to have motional properties similar to those of phospholipids. 
We thus hypothesized that in POPC/Ergosterol MLVs, 13C-Erg would have 13C T1 values similar 
to POPC and would exhibit large PREs in the presence of 16-DOXYL-PC. Moreover, upon 
extraction by AmB, we hypothesized that ergosterol would then become part of the large, 
extramembranous aggregate, resulting in an increase in the T1 values for 13C-Erg with a 
corresponding decrease in PRE effects.   
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To perform this series of experiments we prepared the following samples for analysis: 
POPC:13C-Erg 40:1 ± 16-DOXYL-PC, POPC:AmB:13C-Erg 40:4:2 ± 16-DOXYL-PC, and 
POPC:AmB:13C-Erg 40:4:1 ± 16-DOXYL-PC. The values for the POPC and ergosterol T1 
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values are shown in Figure 4-4 for the POPC/13C-Erg 40:1 sample (no DOXYL-PC). As 
predicted these two molecules have similar T1’s under these conditions. 
 
 
Figure 4-4.  13C Longitudinal relaxation time (T1) for POPC and ergosterol in MLVs composed of POPC/13C-
ergosterol 40:1. 
As shown in Figure 4-5A, we observe a broadening, and in some cases a substantial (> 
0.5 ppm) perturbation of the ergosterol resonances upon addition of AmB. Both of these 
observations are consistent with a change in environment of some portion of ergosterol upon 
addition of AmB (see Discussion section). To accurately asses the PREs for 13C-Erg the 
integration boundaries were set according to the following criteria. (1) No overlap with 
neighboring resonances. (2) For chemical shift diefferences < 0.7 ppm, include the area for both 
the original and new, broad peak. (3) In cases where chemical shift differences > 1.0 ppm, 
include the area for only the original or new broad peak, with no overlap. In the cases where 
conditions 1 and 2 were satisfied, the average PRE is determined. As shown in Figure 4-5B, the 
T1 values for the 13C nuclei of ergosterol increase with increasing ratios of AmB:ergosterol. In 
addition, the average PRE for the same 13C nuclei progressively decrease in the presence of 
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increasing AmB:ergosterol ratio (Figure 4-5C). Interestingly, the peak corresponding to 
ergosterol Erg-9 moves to a new position upon binding to AmB (Erg-9 and Erg-9', respectively, 
in Figure 4-5). The T1 of Erg-9' is longer than that of Erg-9, and there is no significant PRE 
observed for Erg-9', consistent with a bound state of ergosterol remote from the 16-DOXYL PC.  
 
Figure 4-5. A) Direct polarization 13C 1D spectra, processed with 50 Hz line broadening. B) Ergosterol T1 values 
increase in the presence of increasing amounts of AmB, consistent with transfer of mobile ergosterol from the lipid 
bilayer into an immobile AmB aggregate. C) Ergosterol 13C PREs decrease with increasing amounts of AmB, 
consistent with removal of ergosterol from proximity to the 16-DOXYL-PC spin label. 
The identification of distinct resonances for the unbound and bound states of ergosterol 
further enabled us to determine the percentage of ergosterol extracted by AmB for each 
AmB:ergosterol ratio. The amount of ergosterol extracted was 51± 8% and 61±8% for the 40:4:1 
and 40:4:2 POPC:AmB:13C-Erg samples, respectively, based on a comparison of the relative 
integrated intensities of bound and unbound Erg 3, 9, 13, 17, 18, and 19 resonances in direct 
polarization 13C 1D spectra. Thus, the results presented in this section are fully consistent with 
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the extraction of ergosterol from a highly mobile lipid environment into a more rigid 
extramembranous environment distant from the 16-DOXYL spin label.   
4-4 13C-31P REDOR SSNMR EXPERIMENTS 
As discussed in Chapter 3, Murata and coworkers reported several different REDOR 
studies of AmB in liposomes. In these studies, small REDOR effects between AmB and 
phospholipid were observed, and these were interpreted as being consistent with the localization 
of AmB within the lipid bilayer membrane. 
Using our functionally validated liposome system, we undertook 13C-31P REDOR 
experiments of MLVs consisting of POPC/U-13C-AmB/ergosterol 10:1:1. Interestingly, these 
studies revealed measurable REDOR dephasing effects ranging from 10-25% for every 
sufficiently resolved peak in the AmB 13C spectrum (Figure 4-6). These included the methyl 
groups C38, C39, C40, and C6' (Figure 4-6A), C1 and C41 carbonyls (Figure 4-6B), hemiketal 
carbons C1 and C13 (Figure 4-6C). Even the bulk signal of the polyol showed ~15% REDOR 
dephasing (Figure 4-6D). While these results indicate some degree of proximity of AmB 13C 
nuclei to 31P of POPC, there were three interesting features of these REDOR effects that strongly 
support an interpretation alternative to membrane localization of AmB.  
First, these REDOR effects are small (generally 10-15%). Second, the REDOR curves 
display asymptotic behavior, and third, the curves never approach 100% REDOR dephasing 
(S/S0 = 0), even after long REDOR periods. Small REDOR effects could be interpreted as a long 
distance between 2 nuclei, but the REDOR curves would be expected to approach 100% 
dephasing at longer REDOR times, and the curves would not have the asymptotic nature 
observed in our data. This effect has been clearly demonstrated by Hong and coworkers in their 
measurements of intramolecular POPC REDOR effects.17  
Our results are thus inconsistent with a system in which each AmB carbon resides at a 
defined distance from the POPC headgroup. Alternatively, they are consistent with an average 
effect created by either 1) a small proportion of AmB residing in the bilayer with proximity to 
POPC headgroups and/or 2) a small proportion of POPC residing within the large AmB 
aggregate (see Discussion section).   
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Figure 4-6. 13C-31P REDOR curves. A) AmB methyl groups. B) Hemiketal carbons C13 and C1'. C) C1 carbonyl. 
D) Bulk polyol. Each curve shows a small amount of dephasing. The asymptotic quality of these curves is consistent 
with the conclusion that only a small amount of AmB are interacting strongly. 
4-5 DISCUSSION  
In contrast to the leading model of AmB self-assembly in lipid bilayers, we have 
discovered that AmB binds to phospholipid bilayers as large, phase-separated aggregates which 
function to extract ergosterol from the membrane. These conclusions provide a structural 
rationale for the recent discovery that AmB primarily kills yeast cells by sequestering ergosterol. 
Just as channel activity is not the major mechanism of AmB antifungal activity, so the ion chanel 
is not the major structural component in the presence of lipid bilayers. We thus propose the sterol 
sponge model for the antifungal activity of AmB wherein large extramembranous aggregates of 
AmB bind to lipid bilayers and extract ergosterol from the yeast cell membrane (Figure 4-7).   
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ion channel model sterol sponge model  
Figure 4-7. For nearly 50 years, the barrel stave ion channel has been the leading model for 
the interaction of AmB with phospholipid bilayers. Based on extensive SSNMR studies of 
liposome-bound AmB, we now propose the sterol sponge model in which large, phase-
separated aggregates of AmB function to extract ergosterol from phospholipid bilayers. 
The SSNMR studies presented in this chapter are inconsistent with the 3 key postulates of 
the ion channel model as a primary structural model for the antifungal activity of AmB: 1) In 
phospholipid bilayers, AmB primarily exists as discrete, nanometer-scale barrel stave pores, 2) 
These pores are embedded in the phsopholipid bilayer, and 3) Ergosterol binds to these 
embedded pores. This section will discuss our data relevant to each of these 3 postulates and the 
impact of our results on our understanding of the AmB ion channel. 
1. T1 measurements suggest AmB primarily exists as a large aggregate. The current 
prevailing model of AmB binding to phospholipid bilayers posits that membrane-bound AmB 
primarily exists as discrete, nanometer-scale pores. Moreover, these pores are predicted to have 
some translational mobility in the bilayer; in other words they have phase behavior similar to the 
lipids. AmB T1 values much larger than those of POPC in our liposome system suggest instead a 
large AmB aggregate. However, T1 relaxation alone does not allow for a definitive conclusion 
about size, since this parameter depends not simply on size, but also on both local and global 
motions.10,11 In the solid-state, T1 relaxation is minimized when the frequency of molecular 
motions are near the Larmor frequency. If the motions of POPC occur at a rate less than the 
Larmor frequency (150 MHz), then the larger AmB T1’s would indicate a larger aggregate. As it 
stands, this T1 result is suggestive, but not definitive, of a large aggregate of AmB.   
2. PRE studies indicate AmB is not embedded. The ion channel model posits that AmB 
pores are embedded in lipid bilayers. In the presence of 5-DOXYL-PC or 16-DOXYL-PC, nuclei 
in an embedded pore would experience a significant PRE as a result of their position within the 
bilayer proximal to either one or both of the nitroxyl spin labels. We have demonstrated that 
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AmB has no significant PRE in the presence of either 5-DOXYL-PC or 16-DOXYL-PC. Thus, 
we concluded that the large AmB aggregate discussed above does not reside within the 
phospholipid bilayer but rather resides phase-separated from membrane phospholipids.  
Of note in this experiment is the AmB polyene. While AmB polyene signals are not 
resolved to enable site-specific PRE analysis of this portion of the molecule, the broad polyene 
peak as a whole can be analyzed for PRE effects. As depicted in the bar graphs in Figure 4-2 C 
and D, no PRE is observed for the AmB polyene. Examination of 1D spectra further confirm this 
result – the polyene signal is not broadened or decreased in intensity by the presence of either 
DOXYL-PC. 
3. Ergosterol PREs in the presence of increasing amounts of AmB indicates ergosterol 
is physically removed from the bilayer. In the ion channel model of AmB antifungal activity, 
ergosterol is sequestered by the embedded AmB pore. One- and two- dimensional 13C spectra of 
liposome-bound ergosterol indicate that in the presence of AmB, several resonances experience a 
change in chemical shift and dramatic line broadening. Moreover, increased T1 values are 
observed for ergosterol, consistent with loss of mobility upon binding to the large AmB 
aggregate. These observations alone are not sufficient to differentiate the ion channel model from 
the sterol sponge model. However, PRE studies of ergosterol indicate that ergosterol has a robust 
PRE in the presence of 16-DOXYL-PC. When AmB is present in the system, there is a decrease 
in this PRE effect for resolved peaks in the spectrum. Moreover, these ergosterol PREs decrease 
to a greater extent as the amount of AmB in the system increases, consistent with an equilibrium 
between bound and unbound ergosterol, with additional AmB driving the extraction forward. 
The REDOR data presented above are further consistent with the sterol sponge model in 
which AmB and phospholipid are not intimately mixed. Further studies will be required to 
understand the significance of the small REDOR effects observed. However, as mentioned above, 
we conclude that either a small amount of AmB resides in the bilayer and/or a small amount of 
phospholipid is extracted into the AmB aggregate. Given that AmB forms ion channels, the first 
of these postulates is likely to be true; it is possible that a small amount of AmB embedded as an 
ion channel contributes to these small REDOR effects. Consideration of the second postulate is 
very interesting and perhaps implies a specific binding site within the AmB aggregate that binds 
ergosterol and is also a competent host for POPC when ergosterol does not fill all of these 
binding sites. This binding site theory could be tested by REDOR. We performed our REDOR 
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experiments at 10:1:1 POPC/AmB/Ergosterol and observed 10-25% REDOR dephasing for each 
resolved AmB resonance. If POPC indeed binds competitively with ergosterol to the AmB 
aggregate, then increasing the amount of ergosterol in the system should decrease the observed 
REDOR dephasing. 
Reviewing Murata’s REDOR results through the lens of the SSNMR data in this chapter 
reveals several key points. First, the magnitude of REDOR effects reported ranged from 10% to 
50%. Consistent with our own observations, a 100% REDOR effect was never observed in either 
saturated or POPC liposomes. It is thus possible that these moderate REDOR effects represent 
binding of phospholipid to an AmB aggregate. Very interestingly, Murata observed greatest 
REDOR dephasing (~50%) in liposomes lacking ergosterol, consistent with the possibility that 
more phospholipid was able to occupy sites within the AmB aggregate.   
In retrospect, other reports from Murata’s lab are also consistent with the sterol sponge 
model. In the context of studying biophysical properties of AmB derivatives with intramolecular 
tethers between the C41 carboxylate and the C3' amine, Murata reports a large, relatively 
immobile AmB aggregate of >20 nm, fully consistent with our conclusion that the majority of 
AmB primarily exists within a large aggregate.  
In addition, the deuterium mobility study is very interesting in light of our work. The 
observation that AmB and ergosterol have similar mobilities is expected, given that there is a 
direct binding interaction between these two small molecules in lipid bilayers. Our results 
provide further evidence that ergosterol is immobilized by AmB as a result of AmB extracting 
ergosterol from the lipid bilayer and binding it in t   
A final observation by Murata’s group is very though-provoking. Again in their paper on 
13C-Erg,18 they report REDOR data consistent with both head-to-head and head-to-tail 
orientation of ergosterol relative to AmB, implying that AmB itself could aggregate in head-to-
tail fashion. The capacity for AmB to form head-to-tail dimmers in solution has been reported,19 
and in our own 13C-13C DARR spectra, we observed through space interactions between C19 and 
C34 (among other anomalous crosspeaks). These atoms reside on opposite ends of the AmB 
scaffold, thus implying a head-to-tail orientation of AmB in our samples. Thus, as AmB extracts 
ergosterol from the membrane, it is possible that within the AmB aggregate some proportion of 
AmB participates in head-to-tail dimerization.  
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Our discoveries leading to development of the sterol sponge model represent a significant 
advancement of our understanding of the structural underpinnings of AmB antifungal activity.  
Yet, AmB retains the capacity to form channels in the presence of the sterol sponge. We are still 
intensely interested in the capacity of AmB to perform this protein-like function, and 
understanding the structural underpinnings of the AmB ion channel remains as a significant 
challenge for our research group. Insofar as we have observed in the studies presented herein, 
there is no definitive NMR evidence for the structure of this ion channel. The most likely reason 
for this observation is that only a small amount of AmB participates in forming the ion channel 
at any given time and thus is not observable by NMR. Indeed, AmB is known to form ion 
channels at ratios of AmB to PC as low as 1:1000.20 The challenge in studying the ion channel is 
thus isolating the channel in a phospholipid membrane without the accompanying large AmB 
aggregate.  
Reviewing the data presented in chapter 3 reveals that nanodiscs may still be useful for 
trapping the AmB ion channel. While the majority of AmB in our nanodisc studies typically 
eluted at the void volume with MSP, small amounts of AmB did elute at the same retention time 
as the nanodiscs, implying that a small proportion of AmB was bound within these nanodiscs. If 
conditions could be found to cleanly isolate and concentrate large quantities of nanodisc-
embedded AmB, these discs could be prepared for SSNMR analysis. Thus, the nanodisc platform 
still has potential to enable direct study of the AmB ion channel by SSNMR.   
4-6 DISSERTATION SUMMARY 
The studies described in this dissertation have fundamentally altered our understanding of 
the mechanism of AmB and opened new avenues for studying its biological and biophysical 
properties The functional group deletion strategy has proved incredibly powerful in studying the 
salt bridge hypothesis for channel stabilization. We demonstrated through this approach that 
oxidation at C41 is not required for antifungal activity of AmB. High resolution solution NMR 
experiments directly enabled this study by providing the ability to determine the ground state 
conformation of AmB and our derivatives. Subsequently, this functional group deletion strategy 
has  successfully been applied by Gray et al. in our laboratories to synthesize and study the 
activity of C-35-deoxy-AmB, and these studies led to the striking discovery that binding 
ergosterol is the primary mechanism of AmB antifungal activity. Efforts are currently underway 
in our laboratories toward synthesis and study of other functional group deficient derivatives.  
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In addition to demonstrating the power of the functional group deletion strategy, the 
studies described herein highlight the power of SSNMR for study of membrane-bound small 
molecules. In contrast to 50 years of research on the biophysical properties of AmB, we have 
demonstrated that the AmB ion channel is not the primary structural entity of membrane-bound 
AmB. This structural conclusion beautifully parallels the functional observation that ion channel 
activity is not the primary contributor to antifungal activity. In addition, our SSNMR studies 
have established a platform for future studies of AmB, and this technique promises to provide 
fruitful ground for discovery as this collaborative research program moves forward to new 
challenges in studying AmB. Ultimately, we envision SSNMR has the potential to fully elucidate 
the structural underpinnings of the functional properties of AmB, thus enabling us to harness the 
untapped potential of this fascinating small molecule. 
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4-7 EXPERIMENTAL SECTION 
Biosynthesis of 13C-Ergosterol. Biosynthesis of 13C-Erg was performed using a modified 
version of the protocol reported by Seo et al.21 Saccharomyces cerevisiae were incubated at 28 
ºC and 140 r.p.m. for 48 h in a synthetic medium (2 x 1 L) containing sodium [1,2-13C2]acetate 
(450 mg/L), glucose (20.0 g/L), yeast nitrogen base (13.4 g/L), and L-asparagine monohydrate 
(3.0 mg/L). The cells were collected by centrifugation and refluxed with 15% potassium 
hydroxide in ethanol (200 ml) under nitrogen. The filtrate was diluted with water (300 mL) and 
extracted with ether (3 x 400 mL). The extracts were washed with water, dried, and evaporated 
to give a crude extract which was crystallized from methanol-chloroform to afford ergosterol 
SSNMR Experiments. MAS SSNMR experiments were performed at 600 MHz 1H frequency 
on Varian InfinityPlus spectrometer, with a 3.2-mm Varian T3 probe at an MAS rate of 10 kHz. 
The temperature control point was set to 20 °C, and actual sample temperature of 19.5 °C for all 
experiments, as calibrated by ethylene glycol.22  All experiments utilized an average of 70-85 
kHz SPINAL23,24 decoupling of protons applied during evolution and acquisition periods, and 
Tangent ramped cross-polarization (CP)25  where relevant. Chemical shift assignments were 
confirmed using a combination of 13C 1D and 13C-13C 2D spectra acquired with 100, 250, and 
500ms DARR mixing.  Chemical shifts are references to adamantane.26    
 Measurements of longitudinal relaxation rates, R1, were performed using a 13C direct 
polarization (DP) T1 inversion recovery sequence, with 75 kHz of SPINAL proton decoupling 
applied during acquisition. In addition, a short 1ms echo was applied prior to acquisition to 
remove background from probe, and rotor parts in final spectra.  To insure uniformity in the 
determination of R1 values for resolved 13C resonances, integration boundaries were set based on 
the observed linewidth in the 1D and 2D 13C spectra, with small adjustments (>0.3 ppm)  maid to 
avoid overlap when possible.  
De novo assignments for 13C-Erg were made from DARR spectra. The chemical shifts of 
both the bound and free ergosterol are shown in Table 4-1. The column at the right lists the 
number of spectra used to calculate the standard deviation for the chemical shift.  
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 Assignment  δ (ppm) Standard deviation Assignments 
Erg-1 41.18 0.04 29
Erg-3 72.02 0.04 37
Erg-5 143.74 0.05 40
Erg-7 119.75 0.03 30
Erg-9 48.87 0.06 35
Erg-13 45.39 0.07 39
Erg-15 25.95 0.03 22
Erg-17 58.53 0.04 35
Erg-18 14.74 0.04 40
Erg-19 18.59 0.02 18
Erg-21 24.04 0.02 21
Erg-22 138.51 0.04 36
Erg-24 45.93 0.13 30
Erg-26 20.89 0.55 6
Erg-27 22.21 0.33 15
Erg-1' 39.46 0.15 46
Erg-3' 71.44 0.12 59
Erg-5' 144.23 0.15 17
Erg-7' 120.14 0.08 12
Erg-9' 47.36 0.22 79
Erg-13' 44.92 0.10 107
Erg-15' 26.17 0.16 70
Erg-17' 57.39 0.15 77
Erg-18' 15.05 0.17 21
Erg-19' 17.65 0.15 27
Erg-21' 24.45 0.27 4
Erg-22' 139.24 0.14 37
Erg-24' ND   
Erg-26' ND   
Erg-27' ND     
Table 4-1. Ergosterol chemical shift assignments. 
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